 | Up a level |
Weber, M S R; Duran Ramirez, J J; Hentzien, M; Cavassini, M; Bernasconi, E; Hofmann, E; Furrer, H; Kovari, H; Stöckle, M; Schmid, P; Haerry, D; Braun, D L; Günthard, H F; Kusejko, K (2024). Time Trends in Causes of Death in People with HIV: Insights from the Swiss HIV Cohort Study. Clinical infectious diseases, 79(1), pp. 177-188. Oxford University Press 10.1093/cid/ciae014
Thoueille, Paul; Saldanha, Susana Alves; Schaller, Fabian; Choong, Eva; Veuve, François; Munting, Aline; Cavassini, Matthias; Braun, Dominique; Günthard, Huldrych F; Duran Ramirez, Jessy J; Surial, Bernard; Furrer, Hansjakob; Rauch, Andri; Ustero, Pilar; Calmy, Alexandra; Stöckle, Marcel; Di Benedetto, Caroline; Bernasconi, Enos; Schmid, Patrick; Marzolini, Catia; ... (2024). Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIV. Clinical pharmacology and therapeutics, 115(6), pp. 1450-1459. Wiley 10.1002/cpt.3240
Riebensahm, Carlotta; Berzigotti, Annalisa; Surial, Bernard; Haerry, David; Günthard, Huldrych F; Tarr, Philip E; Furrer, Hansjakob; Rauch, Andri; Wandeler, Gilles (2024). Decreased physical activity and prolonged sitting time are associated with liver steatosis in people with HIV. Journal of acquired immune deficiency syndromes, 95(2), pp. 179-184. Wolters Kluwer Health 10.1097/QAI.0000000000003328
Thoueille, Paul; Saldanha, Susana Alves; Schaller, Fabian; Choong, Eva; Munting, Aline; Cavassini, Matthias; Braun, Dominique; Günthard, Huldrych F.; Kusejko, Katharina; Surial, Bernard; Furrer, Hansjakob; Rauch, Andri; Rougemont, Mathieu; Ustero, Pilar; Calmy, Alexandra; Stöckle, Marcel; Marzolini, Catia; Di Benedetto, Caroline; Bernasconi, Enos; Schmid, Patrick; ... (2024). Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland. The Lancet regional health. Europe, 36, p. 100793. Elsevier 10.1016/j.lanepe.2023.100793
Knoll, Leonard; Steppacher, Simon Damian; Furrer, Hansjakob; Thurnheer-Zürcher, Maria C; Renz, Nora (2023). High treatment failure rate in haematogenous compared to non-haematogenous periprosthetic joint infection. The Bone & Joint Journal, 105-B(12), pp. 1294-1302. British Editorial Society of Bone and Joint Surgery 10.1302/0301-620X.105B12.BJJ-2023-0454.R1
Zeeb, Marius; Tepekule, Burcu; Kusejko, Katharina; Reiber, Claudine; Kälin, Marisa; Bartl, Lena; Notter, Julia; Furrer, Hansjakob; Hoffmann, Matthias; Hirsch, Hans H; Calmy, Alexandra; Cavassini, Matthias; Labhardt, Niklaus D; Bernasconi, Enos; Braun, Dominique L; Günthard, Huldrych F; Kouyos, Roger D; Nemeth, Johannes (2023). Understanding the decline of incident, active tuberculosis in people with HIV in Switzerland. Clinical infectious diseases, 77(9), pp. 1303-1311. Oxford University Press 10.1093/cid/ciad330
Ingle, Suzanne M; Miro, Jose M; May, Margaret T; Cain, Lauren E; Schwimmer, Christine; Zangerle, Robert; Sambatakou, Helen; Cazanave, Charles; Reiss, Peter; Brandes, Vanessa; Bucher, Heiner C; Sabin, Caroline; Vidal, Francesc; Obel, Niels; Mocroft, Amanda; Wittkop, Linda; D'arminio Monforte, Antonella; Torti, Carlo; Mussini, Cristina; Furrer, Hansjakob; ... (2023). Early antiretroviral therapy not associated with higher cryptococcal meningitis mortality in people with HIV in high-income countries: an international collaborative cohort study. Clinical infectious diseases, 77(1), pp. 64-73. Oxford University Press 10.1093/cid/ciad122
Bigler, Dina; Surial, Bernard; Hauser, Christoph Victor; Konrad, Torsten; Furrer, Hansjakob; Rauch, Andri; Aebi-Popp, Karoline (2023). Prevalence of STIs and people's satisfaction in a general population STI testing site in Bern, Switzerland. Sexually transmitted infections, 99(4), pp. 268-271. BMJ Publishing Group 10.1136/sextrans-2022-055472
Lundgren, Jens D; Babiker, Abdel G; Sharma, Shweta; Grund, Birgit; Phillips, Andrew N; Matthews, Gail; Kan, Virginia L; Aagaard, Bitten; Abo, Inka; Alston, Beverly; Arenas-Pinto, Alejandro; Avihingsanon, Anchalee; Badal-Faesen, Sharlaa; Brites, Carlos; Carey, Cate; Casseb, Jorge; Clarke, Amanda; Collins, Simon; Corbelli, Giulio Maria; Dao, Sounkalo; ... (2023). Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection. NEJM Evidence, 2(3) NEJM Group 10.1056/evidoa2200302
Gabrielaite, Migle; Bennedbæk, Marc; Rasmussen, Malthe Sebro; Kan, Virginia; Furrer, Hansjakob; Flisiak, Robert; Losso, Marcelo; Lundgren, Jens D; Marvig, Rasmus L (2023). Deep-sequencing of viral genomes from a large and diverse cohort of treatment-naive HIV-infected persons shows associations between intrahost genetic diversity and viral load. PLoS computational biology, 19(1), e1010756. Public Library of Science 10.1371/journal.pcbi.1010756
Chammartin, Frédérique; Darling, Katharine; Abela, Irene A; Battegay, Manuel; Furrer, Hansjakob; Calmy, Alexandra; Bernasconi, Enos; Schmid, Patrick; Hoffmann, Matthias; Bucher, Heiner C (2022). CD4:CD8 ratio and CD8 cell count and their prognostic relevance for coronary heart disease events and stroke in antiretroviral treated individuals: The Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes JAIDS, 91(5), pp. 508-515. Lippincott Williams & Wilkins 10.1097/QAI.0000000000003094
Riebensahm, Carlotta; Berzigotti, Annalisa; Surial, Bernard; Günthard, Huldrych F; Tarr, Philip E; Furrer, Hansjakob; Rauch, Andri; Wandeler, Gilles (2022). Factors Associated With Liver Steatosis in People With Human Immunodeficiency Virus on Contemporary Antiretroviral Therapy. Open Forum Infectious Diseases, 9(11), ofac538. Oxford University Press 10.1093/ofid/ofac538
Thoueille, Paul; Alves Saldanha, Susana; Schaller, Fabian; Munting, Aline; Cavassini, Matthias; Braun, Dominique; Günthard, Huldrych F; Kusejko, Katharina; Surial, Bernard; Furrer, Hansjakob; Rauch, Andri; Ustero, Pilar; Calmy, Alexandra; Stoeckle, Marcel; Battegay, Manuel; Marzolini, Catia; Andre, Pascal; Guidi, Monia; Buclin, Thierry and Decosterd, Laurent A (2022). Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland. Pharmaceutics, 14(8) MDPI 10.3390/pharmaceutics14081588
Levi, Laura I; Sharma, Shweta; Schleiss, Mark R; Furrer, Hansjakob; Nixon, Daniel E; Blackstad, Mark; Hernandez-Alvarado, Nelmary; Dwyer, Dominic E; Borges, Alvaro H; Lane, H Clifford; Lundgren, Jens; Neaton, James D; Molina, Jean-Michel (2022). Cytomegalovirus viremia and risk of disease progression and death in HIV-positive patients starting antiretroviral therapy. AIDS, 36(9), pp. 1265-1272. Wolters Kluwer Health 10.1097/QAD.0000000000003238
Tepekule, Burcu; Kusejko, Katharina; Zeeb, Marius; Tarr, Philip E; Calmy, Alexandra; Battegay, Manuel; Furrer, Hansjakob; Cavassini, Matthias; Bernasconi, Enos; Notter, Julia; Günthard, Huldrych F; Nemeth, Johannes; Kouyos, Roger D (2022). Impact of Latent Tuberculosis Infection on the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study. The journal of infectious diseases, 225(12), pp. 2229-2234. Oxford University Press 10.1093/infdis/jiac054
Balakrishna, Suraj; Wolfensberger, Aline; Kachalov, Viacheslav; Roth, Jan A; Kusejko, Katharina; Scherrer, Alexandra U; Furrer, Hansjakob; Hauser, Christoph; Calmy, Alexandra; Cavassini, Matthias; Schmid, Patrick; Bernasconi, Enos; Battegay, Manuel; Günthard, Huldrych F; Kouyos, Roger D (2022). Decreasing incidence and determinants of Bacterial Pneumonia in people with HIV: The Swiss HIV Cohort Study. The journal of infectious diseases, 225(9), pp. 1592-1600. Oxford University Press 10.1093/infdis/jiab573
Scherrer, Alexandra U; Traytel, Anna; Braun, Dominique L; Calmy, Alexandra; Battegay, Manuel; Cavassini, Matthias; Furrer, Hansjakob; Schmid, Patrick; Bernasconi, Enos; Stoeckle, Marcel; Kahlert, Christian; Trkola, Alexandra; Kouyos, Roger D; Tarr, Philip; Marzolini, Catia; Wandeler, Gilles; Fellay, Jacques; Bucher, Heiner; Yerly, Sabine; Suter, Franziska; ... (2022). Cohort Profile Update: The Swiss HIV Cohort Study (SHCS). International journal of epidemiology, 51(1), 33-34j. Oxford University Press 10.1093/ije/dyab141
Duran Ramirez, Jessy J; Ballouz, Tala; Nguyen, Huyen; Kusejko, Katharina; Chaudron, Sandra E; Huber, Michael; Hirsch, Hans H; Perreau, Matthieu; Ramette, Alban; Yerly, Sabine; Cavassini, Matthias; Stöckle, Marcel; Furrer, Hansjakob; Vernazza, Pietro; Bernasconi, Enos; Günthard, Huldrych F; Kouyos, Roger D (2022). Increasing Frequency and Transmission of HIV-1 Non-B Subtypes among Men Who Have Sex with Men in the Swiss HIV Cohort Study. The journal of infectious diseases, 225(2), pp. 306-316. Oxford University Press 10.1093/infdis/jiab360
Meyer, Andreas M J; Sidler, Daniel; Hirzel, Cédric; Furrer, Hansjakob; Ebner, Lukas; Peters, Alan A.; Christe, Andreas; Huynh-Do, Uyen; Walti, Laura N.; Arampatzis, Spyridon (2021). Distinct Clinical and Laboratory Patterns of Pneumocystis jirovecii Pneumonia in Renal Transplant Recipients. Journal of fungi, 7(12) MDPI 10.3390/jof7121072
Ben-Menahem, Shiko; Sialm, Anastassja; Hachfeld, Anna; Rauch, Andri; von Krogh, Georg; Furrer, Hansjakob (2021). How do healthcare providers construe patient complexity? A qualitative study of multimorbidity in HIV outpatient clinical practice. BMJ open, 11(11), e051013. BMJ Publishing Group 10.1136/bmjopen-2021-051013
Pyngottu, Ashima; Scherrer, Alexandra U; Kouyos, Roger; Huber, Michael; Hirsch, Hans; Perreau, Matthieu; Yerly, Sabine; Calmy, Alexandra; Cavassini, Matthias; Stöckle, Marcel; Furrer, Hansjakob; Vernazza, Pietro; Bernasconi, Enos; Günthard, Huldrych F (2021). Predictors of virological failure and time to viral suppression of first line integrase inhibitor based antiretroviral treatment. Clinical infectious diseases, 73(7), e2134-e2141. Oxford University Press 10.1093/cid/ciaa1614
Schoenbaechler, Valérie; Guilavogui, Yakpazouo; Onivogui, Sosso; Hébélamou, Jean; Mugglin, Catrina; Furrer, Hansjakob; Henzen, Corina; Bavogui, Esther Kolou; Kolié, Cécé; Zoumanigui, Pévé; Béavogui, Ismaël; Leuenberger, David; Staehelin, Cornelia (2021). Rate of treatment success and associated factors in the program for drug susceptible tuberculosis in the Forest Region, Republic of Guinea, 2010-2017: a real-world retrospective observational cohort study. International journal of infectious diseases, 110, pp. 6-14. Elsevier 10.1016/j.ijid.2021.06.014
Atkinson, Andrew; Zwahlen, Marcel; Barger, D; d'Arminio Monforte, A; De Wit, S; Ghosn, J; Girardi, E; Svedhem-Johansson, V; Morlat, P; Mussini, C; Noguera-Julian, A; Stephan, C; Touloumi, G; Kirk, O; Mocroft, A; Reiss, P; Miro, J M; Carpenter, J R; Furrer, Hansjakob (2021). Withholding primary PcP prophylaxis in virologically suppressed HIV patients: An emulation of a pragmatic trial in COHERE. Clinical infectious diseases, 73(2), pp. 195-202. The University of Chicago Press 10.1093/cid/ciaa615
Lehmann, Beat; Baumgartner, Christine; Brill, Anne-Kathrin; Günther, Gunar; Nüesch, Susanne; Ott, Daniel; Ruder, Thomas D.; Thurnheer Zürcher, Maria Christine; Furrer, Hansjakob (2021). [COVID-19 in the Family Practice - Outpatient Treatment or Hospitalization?]. Praxis, 110(9), pp. 517-524. Hogrefe 10.1024/1661-8157/a003686
Jeitziner, Marie-Madlen; Jenni-Moser, Béatrice; Que, Yok-Ai; Thurnheer Zürcher, Maria Christine; Furrer, Hansjakob; Jakob, Stephan (2021). Importance of critical care staffing and standard intensive care therapy in the COVID-19 era: a descriptive study of the first epidemic wave at a Swiss tertiary intensive care unit. Swiss medical weekly, 151, w20529. EMH Media 10.4414/smw.2021.20529
Surial, Bernard; Mugglin, Catrina; Calmy, Alexandra; Cavassini, Matthias; Günthard, Huldrych F; Stöckle, Marcel; Bernasconi, Enos; Schmid, Patrick; Tarr, Philip E; Furrer, Hansjakob; Ledergerber, Bruno; Wandeler, Gilles; Rauch, Andri (2021). Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV : A Cohort Study. Annals of internal medicine, 174(6), pp. 758-767. American College of Physicians 10.7326/M20-4853
Atkinson, Andrew; Miro, Jose M; Mocroft, Amanda; Reiss, Peter; Kirk, Ole; Morlat, Philippe; Ghosn, Jade; Stephan, Christoph; Mussini, Cristina; Antoniadou, Anastasia; Doerholt, Katja; Girardi, Enrico; De Wit, Stéphane; Kraus, David; Zwahlen, Marcel; Furrer, Hansjakob (2021). No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL. Journal of the International AIDS Society, 24(6), e25726. BioMed Central 10.1002/jia2.25726
Glass, Tracy R; Günthard, Huldrych; Calmy, Alexandra; Bernasconi, Enos; Scherrer, Alexandra U; Battegay, Manuel; Steffen, Ana; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Cavassini, Matthias; Furrer, Hansjakob (2021). The role of HIV asymptomatic status when starting ART on adherence and treatment outcomes and implications for test and treat: the Swiss HIV Cohort Study. Clinical infectious diseases, 72(8), pp. 1413-1421. Oxford University Press 10.1093/cid/ciaa239
Castillo-Mancilla, Jose R; Cavassini, Matthias; Schneider, Marie Paule; Furrer, Hansjakob; Calmy, Alexandra; Battegay, Manuel; Scanferla, Giulia; Bernasconi, Enos; Günthard, Huldrych F; Glass, Tracy R (2021). Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study. Open Forum Infectious Diseases, 8(2), ofab032. Oxford University Press 10.1093/ofid/ofab032
Surial, Bernard; Bertholet, Nicolas; Daeppen, Jean-Bernard; Darling, Katharine E A; Calmy, Alexandra; Günthard, Huldrych F; Stöckle, Marcel; Bernasconi, Enos; Schmid, Patrick; Rauch, Andri; Furrer, Hansjakob; Wandeler, Gilles (2021). The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort Study. Journal of clinical medicine, 10(2), p. 295. MDPI 10.3390/jcm10020295
Benet, Susana; Gálvez, Cristina; Drobniewski, Francis; Kontsevaya, Irina; Arias, Lilibeth; Monguió-Tortajada, Marta; Erkizia, Itziar; Urrea, Victor; Ong, Ruo-Yan; Luquin, Marina; Dupont, Maeva; Chojnacki, Jakub; Dalmau, Judith; Cardona, Paula; Neyrolles, Olivier; Lugo-Villarino, Geanncarlo; Vérollet, Christel; Julián, Esther; Furrer, Hansjakob; Günthard, Huldrych F; ... (2021). Dissemination of Mycobacterium tuberculosis is associated to a SIGLEC1 null variant that limits antigen exchange via trafficking extracellular vesicles. Journal of extracellular vesicles, 10(3), e12046. Taylor & Francis 10.1002/jev2.12046
Meier, Noemi Rebecca; Battegay, Manuel; Ottenhoff, Tom H. M.; Furrer, Hansjakob; Nemeth, Johannes; Ritz, Nicole (2021). HIV-Infected Patients Developing Tuberculosis Disease Show Early Changes in the Immune Response to Novel Mycobacterium tuberculosis Antigens. Frontiers in immunology, 12, p. 620622. Frontiers Research Foundation 10.3389/fimmu.2021.620622
Michel, Janet; Stuber, Raphael; Müller, Martin; Mettler, Annette; Furrer, Hansjakob; Ferrand, Rashida A; Exadaktylos, Aristomenis K; Hautz, Wolf E; Sauter, Thomas C (2021). COVID-19 and HIV testing: different viruses but similar prejudices and psychosocial impacts (In Press). Journal of Global Health Reports International Society of Global Health (ISoGH) 10.29392/001c.21403
Surial, Bernard; Essig, Manfred; Furrer, Hansjakob (2021). [Sexually transmitted anorectal infections]. Therapeutische Umschau, 78(9), pp. 540-546. Huber 10.1024/0040-5930/a001308
Kusejko, Katharina; Günthard, Huldrych F; Olson, Gregory S; Zens, Kyra; Darling, Katharine; Khanna, Nina; Furrer, Hansjakob; Vetter, Pauline; Bernasconi, Enos; Vernazza, Pietro; Hoffmann, Matthias; Kouyos, Roger D; Nemeth, Johannes (2020). Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV. PLoS biology, 18(12), e3000963. Public Library of Science 10.1371/journal.pbio.3000963
Surial, Bernard; Béguelin, Charles; Chave, Jean-Philippe; Stöckle, Marcel; Boillat-Blanco, Noémie; Doco-Lecompte, Thanh; Bernasconi, Enos; Fehr, Jan; Günthard, Huldrych F; Schmid, Patrick; Walti, Laura N.; Furrer, Hansjakob; Rauch, Andri; Wandeler, Gilles (2020). Switching from TDF to TAF in HIV/HBV co-infected individuals with renal dysfunction - a prospective cohort study. Journal of acquired immune deficiency syndromes JAIDS, 85(2), pp. 227-232. Lippincott Williams & Wilkins 10.1097/QAI.0000000000002429
Bühler, Silja; Jaeger, Veronika Katharina; Eperon, Gilles; Furrer, Hansjakob; Fux, Christoph A; Jansen, Stephanie; Neumayr, Andreas; Rochat, Laurence; Schmid, Sabine; Schmidt-Chanasit, Jonas; Staehelin, Cornelia; de Visser, Adriëtte W; Visser, Leonardus G; Niedrig, Matthias; Hatz, Christoph (2020). Safety and immunogenicity of a primary yellow fever vaccination under low-dose methotrexate therapy-a prospective multi-centre pilot study1. Journal of travel medicine, 27(6) Oxford University Press 10.1093/jtm/taaa126
Gryaznov, Dmitry; Chammartin, Frédérique; Stoeckle, Marcel; Anagnostopoulos, Alexia; Braun, Dominique Laurent; Furrer, Hansjakob; Boillat-Blanco, Noémie; Bernasconi, Enos; Schmid, Patrick; Nordmann, Alain; Bucher, Heiner C. (2020). Smartphone app and carbon monoxide self-monitoring support for smoking cessation. JAIDS journal of acquired immune deficiency syndromes, 85(1), e8-e11. Wolters Kluwer Health 10.1097/QAI.0000000000002396
Roen, A O; Podlekareva, D; Miller, R F; Mocroft, A; Panteleev, A; Skrahina, A; Miro, J M; Cayla, J A; Tetradov, S; Derisova, E; Furrer, H; Losso, M H; Vassilenko, A; Girardi, E; Lundgren, J D; Post, F A; Kirk, O (2020). A new health care index predicts short term mortality for TB and HIV co-infected people. The international journal of tuberculosis and lung disease, 24(9), pp. 956-962. IUATLD 10.5588/ijtld.19.0568
Surial, Bernard; Ledergerber, Bruno; Calmy, Alexandra; Cavassini, Matthias; Günthard, Huldrych F; Kovari, Helen; Stöckle, Marcel; Bernasconi, Enos; Schmid, Patrick; Fux, Christoph A; Furrer, Hansjakob; Rauch, Andri; Wandeler, Gilles (2020). Changes in renal function after switching from TDF to TAF in HIV-infected individuals: a prospective cohort study. Journal of infectious diseases, 222(4), pp. 637-645. Oxford University Press 10.1093/infdis/jiaa125
Egli, Adrian; Battegay, Manuel; Büchler, Andrea C; Bühlmann, Peter; Calandra, Thierry; Eckert, Philippe; Furrer, Hansjakob; Greub, Gilbert; Jakob, Stephan M.; Kaiser, Laurent; Leib, Stephen L.; Marsch, Stephan; Meinshausen, Nicolai; Pagani, Jean-Luc; Pugin, Jerome; Rätsch, Gunnar; Schrenzel, Jacques; Schüpbach, Reto; Siegemund, Martin; Zamboni, Nicola; ... (2020). SPHN/PHRT: Forming a Swiss-Wide Infrastructure for Data-Driven Sepsis Research. Studies in health technology and informatics, 270, pp. 1163-1167. IOS Press 10.3233/SHTI200346
Keller, Peter M; Furrer, Hansjakob (2020). Think tuberculosis-but is thinking enough? The lancet. Infectious diseases, 20(6), pp. 639-640. Elsevier 10.1016/S1473-3099(20)30138-9
Bossart, Simon; Mühlethaler, Konrad; Garzoni, Christian; Furrer, Hansjakob (2020). Is real time PCR preferable to the direct immunofluorescence in the diagnosis of Pneumocystis jirovecii pneumonia in HIV-infected patients? BMC research notes, 13(1), p. 235. Biomed Central 10.1186/s13104-020-05075-5
Boschung-Pasquier, Léna; Atkinson, Andrew; Kastner, Leonie Kassandra; Banholzer, Sarah; Haschke, Manuel; Buetti, Niccolò; Furrer, Dominique I; Hauser, Christoph; Jent, Philipp; Que, Yok-Ai; Furrer, Hansjakob; Babouee Flury, Baharak (2020). Cefepime neurotoxicity: thresholds and risk factors. A Retrospective Cohort study. Clinical microbiology and infection, 26(3), pp. 333-339. Elsevier 10.1016/j.cmi.2019.06.028
Dietrich, Léna G; Barceló, Catalina; Thorball, Christian W; Ryom, Lene; Burkhalter, Felix; Hasse, Barbara; Furrer, Hansjakob; Weisser, Maja; Steffen, Ana; Bernasconi, Enos; Cavassini, Matthias; de Seigneux, Sophie; Csajka, Chantal; Fellay, Jacques; Ledergerber, Bruno; Tarr, Philip E (2020). Contribution of genetic background and clinical D:A:D risk score to chronic kidney disease in Swiss HIV-positive persons with normal baseline estimated glomerular filtration rate. Clinical infectious diseases, 70(5), pp. 890-897. Oxford University Press 10.1093/cid/ciz280
Barceló, Catalina; Guidi, Monia; Thorball, Christian W; Hammer, Christian; Chaouch, Aziz; Scherrer, Alexandra U; Hasse, Barbara; Cavassini, Matthias; Furrer, Hansjakob; Calmy, Alexandra; Haubitz, Sebastian; Bernasconi, Enos; Buclin, Thierry; Fellay, Jacques; Tarr, Philip E; Csajka, Chantal (2020). Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral Therapy. Open Forum Infectious Diseases, 7(1), ofz464. Oxford University Press 10.1093/ofid/ofz464
Lo Priore, Elia; Livermore, David M; Buetti, Niccolo; Jent, Philipp; Pelzer, Niklas; Casanova, Carlo; Furrer, Hansjakob; Babouee Flury, Baharak (2020). Successful Treatment of Acute Prostatitis Caused by Multidrug-Resistant Escherichia coli With Tigecycline Monotherapy. Open Forum Infectious Diseases, 7(1), ofz551. Oxford University Press 10.1093/ofid/ofz551
Abela, Irene A; Scherrer, Alexandra U; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Perreau, Matthieu; Hirsch, Hans H; Furrer, Hansjakob; Calmy, Alexandra; Schmid, Patrick; Cavassini, Matthias; Bernasconi, Enos; Günthard, Huldrych F (2020). Emergence of drug resistance in the Swiss HIV Cohort Study under potent antiretroviral therapy is observed in socially disadvantaged patients. Clinical infectious diseases, 70(2), pp. 297-303. Oxford University Press 10.1093/cid/ciz178
Surial, Bernard; Cavassini, Matthias; Calmy, Alexandra; Fehr, Jan; Stöckle, Marcel; Bernasconi, Enos; Roth, Bianca; Fux, Christoph A; Kovari, Helen; Furrer, Hansjakob; Rauch, Andri; Wandeler, Gilles (2019). Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort. BMC infectious diseases, 19(1), p. 834. BioMed Central 10.1186/s12879-019-4454-9
Christe, Andreas; Walti, Laura; Charimo, Jaled; Rauch, Andri; Furrer, Hansjakob; Meyer, Andreas; Huynh-Do, Uyen; Heverhagen, Johannes T.; Mueller, Nicolas J; Cavassini, Matthias; Mombelli, Matteo; van Delden, Christian; Frauenfelder, Thomas; Montet, Xavier; Beigelman-Aubry, Catherine; Arampatzis, Spyridon; Ebner, Lukas (2019). Imaging patterns of Pneumocystis jirovecii pneumonia in HIV-positive and renal transplant patients - a multicentre study. Swiss medical weekly, 149(w20130), w20130. EMH Media 10.4414/smw.2019.20130
Wójtowicz, Agnieszka; Bibert, Stéphanie; Taffé, Patrick; Bernasconi, Enos; Furrer, Hansjakob; Günthard, Huldrych F; Hoffmann, Matthias; Osthoff, Michael; Cavassini, Matthias; Bochud, Pierre-Yves (2019). IL-4 polymorphism influences susceptibility to Pneumocystis jirovecii pneumonia in HIV-positive patients. AIDS, 33(11), pp. 1719-1727. Lippincott Williams & Wilkins 10.1097/QAD.0000000000002283
Hachfeld, Anna; Darling, K; Calmy, A; Ledergerber, B; Weber, R; Battegay, M; Wissel, K; Di Benedetto, C; Fux, C A; Tarr, P E; Kouyos, R; Ruggia, LS; Furrer, Hansjakob; Wandeler, Gilles (2019). Why do sub-Saharan Africans present late for HIV care in Switzerland? HIV medicine, 20(6), pp. 418-423. Blackwell Science 10.1111/hiv.12727
Caniglia, Ellen C; Robins, James M; Cain, Lauren E; Sabin, Caroline; Logan, Roger; Abgrall, Sophie; Mugavero, Michael J; Hernández-Díaz, Sonia; Meyer, Laurence; Seng, Remonie; Drozd, Daniel R; Seage Iii, George R; Bonnet, Fabrice; Le Marec, Fabien; Moore, Richard D; Reiss, Peter; van Sighem, Ard; Mathews, William C; Jarrín, Inma; Alejos, Belén; ... (2019). Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individuals. Statistics in medicine, 38(13), pp. 2428-2446. Wiley-Blackwell 10.1002/sim.8120
Donà, Valentina; Scheidegger, Maximilian; do Couto Pires, João Pedro; Furrer, Hansjakob; Atkinson, Andrew; Babouee Flury, Baharak (2019). Gradual in vitro Evolution of Cefepime Resistance in an ST131 Escherichia coli Strain Expressing a Plasmid-Encoded CMY-2 β-Lactamase. Frontiers in Microbiology, 10, p. 1311. Frontiers 10.3389/fmicb.2019.01311
Boatman, Jeffrey A; Baker, Jason V; Emery, Sean; Furrer, Hansjakob; Mushatt, David M; Sedlacek, Dalibor; Lundgren, Jens D; Neaton, James D (2019). Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression among Participants Initiating Antiretroviral Treatment with CD4+ Counts > 500 cells/mm3: Findings from the Strategic Timing of AntiRetroviral Treatment (START) Trial. Journal of acquired immune deficiency syndromes JAIDS, 81(1), pp. 10-17. Wolters Kluwer Health 10.1097/QAI.0000000000001967
Faini, Diana; Kalinjuma, Aneth Vedastus; Katende, Andrew; Mbwaji, Gladys; Mnzava, Dorcas; Nyuri, Amina; Glass, Tracy R; Furrer, Hansjakob; Hatz, Christoph; Boulware, David R; Letang, Emilio (2019). Laboratory-reflex cryptococcal antigen screening is associated with a survival benefit in Tanzania. Journal of acquired immune deficiency syndromes JAIDS, 80(2), pp. 205-213. Lippincott Williams & Wilkins 10.1097/QAI.0000000000001899
Bibert, Stéphanie; Wójtowicz, Agnieszka; Taffé, Patrick; Tarr, Philip E; Bernasconi, Enos; Furrer, Hansjakob; Günthard, Huldrych F; Hoffmann, Matthias; Kaiser, Laurent; Osthoff, Michael; Fellay, Jacques; Cavassini, Matthias; Bochud, Pierre-Yves (2018). Interferon lambda 3/4 polymorphisms are associated with AIDS-related Kaposi's sarcoma. AIDS, 32(18), pp. 2759-2765. Lippincott Williams & Wilkins 10.1097/QAD.0000000000002004
Jent, Philipp; Trippel, Mafalda; Frey, Manuel; Pöllinger, Alexander; Berezowska, Sabina; Langer, Rupert; Furrer, Hansjakob; Béguelin, Charles Antoine (2018). Fatal Measles Virus Infection After Rituximab-Containing Chemotherapy in a Previously Vaccinated Patient. Open Forum Infectious Diseases, 5(11), ofy244. Oxford University Press 10.1093/ofid/ofy244
Aebi-Popp, K; Wandeler, G; Salazar Vizcaya, L; Metzner, K; Stöckle, M; Cavassini, M; Hoffmann, M; Lüthi, A; Suter, F; Bernasconi, E; Fehr, J; Furrer, H; Rauch, A (2018). Rapid decline of anti-hepatitis C virus (HCV) antibodies following early treatment of incident HCV infections in HIV-infected men who have sex with men. HIV medicine, 19(6), pp. 420-425. Blackwell Science 10.1111/hiv.12602
Mapesi, Herry; Kalinjuma, Aneth V; Ngerecha, Alphonce; Franzeck, Fabian; Hatz, Christoph; Tanner, Marcel; Mayr, Michael; Furrer, Hansjakob; Battegay, Manuel; Letang, Emilio; Weisser, Maja; Glass, Tracy R (2018). Prevalence and Evolution of Renal Impairment in People Living With HIV in Rural Tanzania. Open Forum Infectious Diseases, 5(4), ofy072. Oxford University Press 10.1093/ofid/ofy072
Veit, Olivia Stephanie; Domingo, Cristina; Niedrig, Matthias; Staehelin, Cornelia; Sonderegger, Beat; Delphine, Héquet; Stoeckle, Marcel; Calmy, Alexandra; Schiffer, Veronique; Bernasconi, Enos; Flury, Domenica; Hatz, Christoph; Zwahlen, Marcel; Furrer, Hansjakob (2018). Long-term immune response to yellow fever vaccination in HIV-infected individuals depends on HIV-RNA suppression status: Implications for vaccination schedule. Clinical infectious diseases, 66(7), pp. 1099-1108. Oxford University Press 10.1093/cid/cix960
Perrone, Carlo; Rauch, Andri; Furrer, Hansjakob; Hug, Markus; Wandeler, Gilles (2018). Fewer pills do not mean fewer drug-drug interactions: severe rhabdomyolysis on Elvitegravir/Cobicistat and statin treatment. AIDS, 32(5), pp. 676-678. Lippincott Williams & Wilkins 10.1097/QAD.0000000000001746
do Couto Pires, João Pedro; Kuenzli, Esther; Hauser, Christoph; Tinguely, Regula; Kasraian Fard, Sara; Atkinson, Andrew; Rauch, Andri; Furrer, Hansjakob; Perreten, Vincent; Marschall, Jonas; Hatz, Christoph; Endimiani, Andrea (2018). Intestinal Colonization with Extended-Spectrum Cephalosporin-Resistant Enterobacteriaceae in Different Populations in Switzerland: Prevalence, Risk Factors and Molecular Features. Journal of global antimicrobial resistance, 12, pp. 17-19. Elsevier 10.1016/j.jgar.2017.11.007
De Wit, S; Battegay, M; D'Arminio Monforte, A; Lundgren, J D; Oprea, C; Antinori, A; Bhagani, S; Fätkenheuer, G; Friis-Moller, N; Furrer, Hansjakob; Mussini, C (2018). European AIDS Clinical Society Second Standard of Care Meeting, Brussels 16-17 November 2016: a summary. HIV medicine, 19(2), pp. 77-80. Blackwell Science 10.1111/hiv.12559
Efsen, A M W; Schultze, A; Miller, R F; Panteleev, A; Skrahin, A; Podlekareva, D N; Miro, J M; Girardi, E; Furrer, Hansjakob; Losso, M H; Toibaro, J; Caylà, J A; Mocroft, A; Lundgren, J D; Post, F A; Kirk, O (2018). Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study. Journal of infection, 76(1), pp. 44-54. Elsevier 10.1016/j.jinf.2017.10.007
Abraha, Million; Bertisch, Barbara; Hauser, Christoph; Klutschke, Michael; Egli-Gany, Dianne; Smid, Joost; Unemo, Magnus; Endimiani, Andrea; Donà, Valentina; Furrer, Hansjakob; Low, Nicola; Kasraian Fard, Sara (23 November 2017). Factors associated with anitmicrobial resistant gonorrheoea infections in men who have sex with men in Switzerland: case control study. In: Swiss Public Health Conference 2017. Congress Center Basel. 22 - 23 Nov 2017.
Marzel, A; Shilaih, M; Turk, T; Campbell, N K; Yang, W-L; Böni, J; Yerly, S; Klimkait, T; Aubert, V; Furrer, Hansjakob; Calmy, A; Battegay, M; Cavassini, M; Bernasconi, E; Schmid, P; Metzner, K J; Günthard, H F; Kouyos, R D (2017). Mining for pairs: shared clinic visit dates identify steady HIV-positive partnerships. HIV medicine, 18(9), pp. 667-676. Blackwell Science 10.1111/hiv.12507
Turk, Teja; Bachmann, Nadine; Kadelka, Claus; Böni, Jürg; Yerly, Sabine; Aubert, Vincent; Klimkait, Thomas; Battegay, Manuel; Bernasconi, Enos; Calmy, Alexandra; Cavassini, Matthias; Furrer, Hansjakob; Hoffmann, Matthias; Günthard, Huldrych F; Kouyos, Roger D (2017). Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis. eLife, 6 eLife Sciences Publications 10.7554/eLife.28721
Gebreselassie, Hiwot Mamo; Kraus, David; Fux, C A; Haubitz, Sebastian; Scherrer, A; Hatz, C; Veit, O; Stoeckle, M; Fehr, J; de Lucia, S; Cavassini, M; Bernasconi, E; Schmid, P; Furrer, Hansjakob; Stähelin, Cornelia Johanna (2017). Ethnicity predicts viral rebound after travel to the tropics in HIV-infected travelers to the tropics in the Swiss HIV Cohort Study. HIV medicine, 18(8), pp. 564-572. Blackwell Science 10.1111/hiv.12491
Achhra, Amit C; Mocroft, Amanda; Ross, Michael; Ryom-Nielson, Lene; Avihingsanon, Anchalee; Bakowska, Elzbieta; Belloso, Waldo; Clarke, Amanda; Furrer, Hansjakob; Lucas, Gregory M; Ristola, Matti; Rassool, Mohammed; Ross, Jonathan; Somboonwit, Charurut; Sharma, Shweta; Wyatt, Christina (2017). Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START trial. International journal of antimicrobial agents, 50(3), pp. 453-460. Elsevier 10.1016/j.ijantimicag.2017.04.021
Babouee Flury, Baharak; Donà, Valentina; Buetti, Niccolò Ivo Marco-Aurelio; Furrer, Hansjakob; Endimiani, Andrea (2017). First two cases of severe multifocal infections caused by Klebsiella pneumoniae in Switzerland: characterization of an atypical non-K1/K2-serotype strain causing liver abscess and endocarditis. Journal of global antimicrobial resistance, 10, pp. 165-170. Elsevier 10.1016/j.jgar.2017.04.006
Elzi, Luigia; Erb, Stefan; Furrer, Hansjakob; Cavassini, Matthias; Calmy, Alexandra; Vernazza, Pietro; Günthard, Huldrych; Bernasconi, Enos; Battegay, Manuel (2017). Adverse events of raltegravir and dolutegravir. AIDS, 31(13), pp. 1853-1858. Lippincott Williams & Wilkins 10.1097/QAD.0000000000001590
Bauer, Sophie; Wa Mwanza, Mwanza; Chilengi, Roma; Holmes, Charles B; Zyambo, Zude; Furrer, Hansjakob; Egger, Matthias; Wandeler, Gilles; Vinikoor, Michael J (2017). Awareness and management of elevated blood pressure among human immunodeficiency virus-infected adults receiving antiretroviral therapy in urban Zambia: a call to action. Global Health Action, 10(1), p. 1359923. Taylor & Francis 10.1080/16549716.2017.1359923
Do Couto Pires, Joao Pedro; Bernasconi, Odette Joëlle; Hauser, Christoph; Tinguely, Regula; Atkinson, Andrew; Perreten, Vincent; Donà, Valentina; Rauch, Andri; Furrer, Hansjakob; Endimiani, Andrea (2017). Erratum to 'Intestinal colonisation with extended-spectrum cephalosporin- and colistin-resistant Enterobacteriaceae in HIV-positive individuals in Switzerland: molecular features and risk factors' [International Journal of Antimicrobial Agents 49/4 (2017) 519-521]. International journal of antimicrobial agents, 50(2), p. 276. Elsevier 10.1016/j.ijantimicag.2017.05.002
Letang, Emilio; Kalinjuma, Aneth Vedastus; Glass, Tracy R; Gamell, Anna; Mapesi, Herry; Sikalengo, George Rocky; Luwanda, Lameck Bonaventure; Mnzava, Dorcas; Ntamatungiro, Alex J; Ndaki, Regina; Francis, Gideon; Vanobberghen, Fiona; Furrer, Hansjakob; Klimkait, Thomas; Felger, Ingrid; Tanner, Marcel; Hatz, Christoph; Weisser, Maja; Battegay, Manuel (2017). Cohort profile: The Kilombero and Ulanga Antiretroviral Cohort (KIULARCO) - A prospective HIV cohort in rural Tanzania. Swiss medical weekly, 147, w14485. EMH Schweizerischer Ärzteverlag 10.4414/smw.2017.14485
Ntamatungiro, Alex J; Muri, Lukas; Glass, Tracy R; Erb, Stefan; Battegay, Manuel; Furrer, Hansjakob; Hatz, Christoph; Tanner, Marcel; Felger, Ingrid; Klimkait, Thomas; Letang, Emilio (2017). Strengthening HIV therapy and care in rural Tanzania affects rates of viral suppression. Journal of antimicrobial chemotherapy, 72(7), pp. 2069-2074. Oxford University Press 10.1093/jac/dkx095
Fenner, Lukas; Atkinson, Andrew; Boulle, Andrew; Fox, Matthew P; Prozesky, Hans; Zürcher, Kathrin; Ballif, Marie; Furrer, Hansjakob; Zwahlen, Marcel; Davies, Mary-Ann; Egger, Matthias; eDEA-SA, Int. Epidemiology Database to Evaluate AIDS in Southern Africa (2017). HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies. Journal of the International AIDS Society, 20(1), p. 21327. BioMed Central 10.7448/IAS.20.1.21327
Chêne, Geneviève; Phillips, Andrew; Costagliola, Dominique; Sterne, Jonathan A.C.; Furrer, Hansjakob; del Amo, Julia; Mocroft, Amanda; d’Arminio Monforte, Antonella; Dabis, François; Miro, José M.; Barger, Diana; Termote, Monique; Schwimmer, Christine; Salbøl Brandt, Rikke; Friis-Moller, Nina; Raben, Dorthe; Haerry, David; Egger, Matthias; Weller, Ian and De Wit, Stéphane (2017). Cohort Profile: Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. International journal of epidemiology, 46(3), 797-797n. Oxford University Press 10.1093/ije/dyw211
Caniglia, Ellen C; Cain, Lauren E; Sabin, Caroline A; Robins, James M; Logan, Roger; Abgrall, Sophie; Mugavero, Michael J; Hernández-Díaz, Sonia; Meyer, Laurence; Seng, Remonie; Drozd, Daniel R; Seage, George R; Bonnet, Fabrice; Dabis, Francois; Moore, Richard D; Reiss, Peter; van Sighem, Ard; Mathews, William C; Del Amo, Julia; Moreno, Santiago; ... (2017). Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study. The Lancet HIV, 4(6), e251-e259. Elsevier 10.1016/S2352-3018(17)30043-7
Do Couto Pires, Joao Pedro; Bernasconi, Odette Joëlle; Hauser, Christoph; Tinguely, Regula; Atkinson, Andrew; Perreten, Vincent; Donà, Valentina; Rauch, Andri; Furrer, Hansjakob; Endimiani, Andrea (2017). Intestinal colonisation with extended-spectrum cephalosporin- and colistin-resistant Enterobacteriaceae in HIV-positive individuals in Switzerland: molecular features and risk factors. International journal of antimicrobial agents, 49(4), pp. 519-521. Elsevier 10.1016/j.ijantimicag.2017.02.004
Prague, Mélanie; Commenges, Daniel; Gran, Jon Michael; Ledergerber, Bruno; Young, Jim; Thiébaut, Rodolphe; Furrer, Hansjakob (2017). Dynamic models for estimating the effect of HAART on CD4 in observational studies: Application to the Aquitaine Cohort and the Swiss HIV Cohort Study. Biometrics, 73(1), pp. 294-304. The International Biometric Society 10.1111/biom.12564
Güler, Aysel; Moser, André; Calmy, Alexandra; Günthard, Huldrych F; Bernasconi, Enos; Furrer, Hansjakob; Fux, Christoph A; Battegay, Manuel; Cavassini, Matthias; Vernazza, Pietro; Zwahlen, Marcel; Egger, Matthias (2017). Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population. AIDS, 31(3), pp. 427-436. Lippincott Williams & Wilkins 10.1097/QAD.0000000000001335
Podlekareva, D.N.; Schultze, A; Panteleev, A; Skrahina, A.M.; Miro, J.M.; Furrer, Hansjakob; Rakhmanova, A; Miller, R.F.; Efsen, A.M.W.; Losso, M.H.; Toibaro, J; Vassilenko, A; Girardi, E; Lundgren, J.D.; Mocroft, A; Kirk, O (2017). One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America. AIDS, 31(3), pp. 375-384. Lippincott Williams & Wilkins 10.1097/QAD.0000000000001333
Béguelin, Charles Antoine; Moradpour, Darius; Sahli, Roland; Suter, Franziska Marta; Lüthi, Alexander; Cavassini, Matthias; Günthard, Huldrych F; Battegay, Manuel; Bernasconi, Enos; Schmid, Patrick; Calmy, Alexandra; Braun, Dominique; Furrer, Hansjakob; Rauch, Andri; Wandeler, Gilles (2017). Hepatitis delta-associated mortality in HIV/HBV-coinfected patients. Journal of hepatology, 66(2), pp. 297-303. Elsevier 10.1016/j.jhep.2016.10.007
Rodríguez-Arbolí, Eduardo; Mwamelo, Kim; Kalinjuma, Aneth Vedastus; Furrer, Hansjakob; Hatz, Christoph; Tanner, Marcel; Battegay, Manuel; Letang, Emilio (2017). Incidence and risk factors for hypertension among HIV patients in rural Tanzania - A prospective cohort study. PLoS ONE, 12(3), e0172089. Public Library of Science 10.1371/journal.pone.0172089
Vanobberghen, Fiona; Letang, Emilio; Gamell, Anna; Mnzava, Dorcas K; Faini, Diana; Luwanda, Lameck B; Mapesi, Herry; Mwamelo, Kim; Sikalengo, George; Tanner, Marcel; Hatz, Christoph; Furrer, Hansjakob; Battegay, Manuel; Glass, Tracy R (2017). A decade of HIV care in rural Tanzania: Trends in clinical outcomes and impact of clinic optimisation in an open, prospective cohort. PLoS ONE, 12(7), e0180983. Public Library of Science 10.1371/journal.pone.0180983
Low, Nicola; B, Bertisch; Hauser, C; M, Kluschke; Kasraian, S; Egli-Gany, Dianne; Smid, J; M, Unemo; Endimiani, A; Donà, V; Furrer, H (2017). O12.5 Factors associated with antimicrobial resistant gonorrhoea infections in men who have sex with men: case-control study. Sexually transmitted infections, 93(Suppl 2), A28.2-A28. BMJ Publishing Group 10.1136/sextrans-2017-053264.70
Sauter, Rafael; Huang, Ruizhu; Ledergerber, Bruno; Battegay, Manuel; Bernasconi, Enos; Cavassini, Matthias; Furrer, Hansjakob; Hoffmann, Matthias; Rougemont, Mathieu; Günthard, Huldrych F; Held, Leonhard (2016). CD4/CD8 ratio and CD8 counts predict CD4 response in HIV-1-infected drug naive and in patients on cART. Medicine, 95(42), e5094. Lippincott Williams & Wilkins 10.1097/MD.0000000000005094
Muri, Lukas; Gamell, Anna; Ntamatungiro, Alex J; Glass, Tracy R; Luwanda, Lameck B; Battegay, Manuel; Furrer, Hansjakob; Hatz, Christoph; Tanner, Marcel; Felger, Ingrid; Klimkait, Thomas; Letang, Emilio (2016). Development of HIV drug resistance and therapeutic failure in children and adolescents in rural tanzania - an emerging public health concern. AIDS, 31(1), pp. 61-70. Lippincott Williams & Wilkins 10.1097/QAD.0000000000001273
Salazar-Vizcaya, Luisa; Kouyos, Roger D; Zahnd, Cindy; Wandeler, Gilles; Battegay, Manuel; Darling, Katharine Elizabeth Ana; Bernasconi, Enos; Calmy, Alexandra; Vernazza, Pietro; Furrer, Hansjakob; Egger, Matthias; Keiser, Olivia; Rauch, Andri (2016). Hepatitis C virus transmission among HIV-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions. Hepatology, 64(6), pp. 1856-1869. Wiley Interscience 10.1002/hep.28769
Hirzel, Cédric; Hirzberger, Lea; Furrer, Hansjakob; Endimiani, Andrea (2016). Bactericidal activity of penicillin, ceftriaxone, gentamicin and daptomycin alone and in combination against Aerococcus urinae. International journal of antimicrobial agents, 48(3), pp. 271-276. Elsevier 10.1016/j.ijantimicag.2016.05.007
Stucki, David; Ballif, Marie; Egger, Matthias; Furrer, Hansjakob; Altpeter, Ekkehardt; Battegay, Manuel; Droz, Sara Christine; Bruderer, Thomas; Coscolla, Mireia; Borrell, Sonia; Zürcher, Kathrin; Janssens, Jean-Paul; Calmy, Alexandra; Mazza Stalder, Jesica; Jaton, Katia; Rieder, Hans L; Pfyffer, Gaby E; Siegrist, Hans H; Hoffmann, Matthias; Fehr, Jan; ... (2016). Standard genotyping overestimates transmission of Mycobacterium tuberculosis among immigrants in a low incidence country. Journal of clinical microbiology, 54(7), pp. 1862-1870. American Society for Microbiology 10.1128/JCM.00126-16
Donà, Valentina; Kasraian Fard, Sara; Lupo, Agnese; Guilarte, Yuvia N; Hauser, Christoph; Furrer, Hansjakob; Unemo, Magnus; Low, Nicola; Endimiani, Andrea (2016). A Multiplex Real-Time PCR with High Resolution Melting Analysis for the Characterization of Antimicrobial Resistance in Neisseria gonorrhoeae. Journal of clinical microbiology, 54(8), JCM.03354-15. American Society for Microbiology 10.1128/JCM.03354-15
Stuehler, Claudia; Bernardini, Claudia; Elzi, Luigia; Stoeckle, Marcel; Zimmerli, Stefan; Furrer, Hansjakob; Günthard, Huldrych F; Leibundgut-Landmann, Salomé; Battegay, Manuel; Khanna, Nina (2016). Immune recovery in HIV-infected patients after candida esophagitis is impaired despite long-term antiretroviral therapy. AIDS, 30(12), p. 1. Lippincott Williams & Wilkins 10.1097/QAD.0000000000001126
Winter, Annja; Letang, Emilio; Kalinjuma, Aneth Vedastus; Kimera, Namvua; Ntamatungiro, Alex; Glass, Tracy; Moradpour, Darius; Sahli, Roland; Le Gal, Frédéric; Furrer, Hansjakob; Wandeler, Gilles (2016). Absence of Hepatitis Delta Infection in a Large Rural HIV Cohort in Tanzania. International journal of infectious diseases, 46, pp. 8-10. Elsevier 10.1016/j.ijid.2016.03.011
Scherrer, Alexandra U; von Wyl, Viktor; Yang, Wan-Lin; Kouyos, Roger; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Cavassini, Matthias; Battegay, Manuel; Furrer, Hansjakob; Calmy, Alexandra; Vernazza, Pietro; Bernasconi, Enos; Günthard, Huldrych F (2016). Emergence of acquired HIV-1 drug resistance has almost been stopped in Switzerland - a 15 year prospective cohort analysis. Clinical infectious diseases, 62(10), pp. 1310-1317. Oxford University Press 10.1093/cid/ciw128
Wandeler, Gilles; Kraus, David; Fehr, Jan; Conen, Anna; Calmy, Alexandra; Orasch, Christina; Battegay, Manuel; Schmid, Patrick; Bernasconi, Enos; Furrer, Hansjakob (2016). The J-curve in HIV: low and moderate alcohol intake predicts mortality but not the occurrence of major cardiovascular events. Journal of acquired immune deficiency syndromes JAIDS, 71(3), pp. 302-9. Lippincott Williams & Wilkins 10.1097/QAI.0000000000000864
Podlekareva, Daria N; Efsen, Anne Marie W; Schultze, Anna; Post, Frank A; Skrahina, Alena M; Panteleev, Alexander; Furrer, Hansjakob; Miller, Robert F; Losso, Marcelo H; Toibaro, Javier; Miro, Jose M; Vassilenko, Anna; Girardi, Enrico; Bruyand, Mathias; Obel, Niels; Lundgren, Jens D; Mocroft, Amanda; Kirk, Ole (2016). Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study. The Lancet HIV, 3(3), e120-e131. Elsevier 10.1016/S2352-3018(15)00252-0
McLaren, Paul J; Raisaro, Jean Louis; Aouri, Manel; Rotger, Margalida; Ayday, Erman; Bartha, István; Delgado, Maria B; Vallet, Yannick; F Günthard, Huldrych; Cavassini, Matthias; Furrer, Hansjakob; Doco-Lecompte, Thanh; Marzolini, Catia; Schmid, Patrick; Di Benedetto, Caroline; Decosterd, Laurent A; Fellay, Jacques; Hubaux, Jean-Pierre; Telenti, Amalio (2016). Privacy-preserving genomic testing in the clinic: a model using HIV treatment. Genetics in medicine, 18(8), pp. 814-822. Palgrave Macmillan 10.1038/gim.2015.167
Marzel, Alex; Shilaih, Mohaned; Yang, Wan-Lin; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Braun, Dominique L; Calmy, Alexandra; Furrer, Hansjakob; Cavassini, Matthias; Battegay, Manuel; Vernazza, Pietro L; Bernasconi, Enos; Günthard, Huldrych F; Kouyos, Roger D (2016). HIV-1 Transmission During Recent Infection and During Treatment Interruptions as Major Drivers of New Infections in the Swiss HIV Cohort Study. Clinical infectious diseases, 62(1), pp. 115-122. Oxford University Press 10.1093/cid/civ732
Elzi, Luigia; Conen, Anna; Patzen, Annalea; Fehr, Jan; Cavassini, Matthias; Calmy, Alexandra; Schmid, Patrick; Bernasconi, Enos; Furrer, Hansjakob; Battegay, Manuel (2016). Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy: The Swiss HIV Cohort Study. Open Forum Infectious Diseases, 3(1), ofw022. Oxford University Press 10.1093/ofid/ofw022
Noguera-Julian, Marc; Cozzi-Lepri, Alessandro; Di Giallonardo, Francesca; Schuurman, Rob; Däumer, Martin; Aitken, Sue; Ceccherini-Silberstein, Francesca; D'Arminio Monforte, Antonella; Geretti, Anna Maria; Booth, Claire L; Kaiser, Rolf; Michalik, Claudia; Jansen, Klaus; Masquelier, Bernard; Bellecave, Pantxika; Kouyos, Roger D; Castro, Erika; Furrer, Hansjakob; Schultze, Anna; Günthard, Huldrych F; ... (2016). Contribution of APOBEC3G/F Activity to the Development of Low-Abundance Drug-Resistant HIV-1 variants. Clinical microbiology and infection, 22(2), pp. 191-200. Blackwell Publishing 10.1016/j.cmi.2015.10.004
Hirzel, Cédric; Donà, Valentina; Guilarte, Yuvia; Furrer, Hansjakob; Marschall, Jonas; Endimiani, Andrea (2016). Clonal analysis of Aerococcus urinae isolates by using the repetitive extragenic palindromic PCR (rep-PCR). Journal of infection, 72(2), pp. 262-265. Elsevier 10.1016/j.jinf.2015.11.001
Stähelin, Cornelia Johanna; Hirzel, Cédric; Hauser, Christoph; Furrer, Hansjakob (2016). [Vaccinations for immunocompromised hosts – focussing on patients after a hematological stem cell or organ transplantation, with HIV or with functional or anatomical asplenia]. Therapeutische Umschau, 73(5), pp. 281-289. Huber 10.1024/0040-5930/a000793
Zimmermann, Petra Sabine; Mühlethaler, Konrad; Furrer, Hansjakob; Stähelin, Cornelia Johanna (2016). Travellers returning ill from the tropics – a descriptive retrospective study. Tropical Diseases, Travel Medicine and Vaccines, 2(1) BioMed Central 10.1186/s40794-016-0021-1
Shilaih, Mohaned; Marzel, Alex; Yang, Wan Lin; Scherrer, Alexandra U; Schüpbach, Jörg; Böni, Jürg; Yerly, Sabine; Hirsch, Hans H; Aubert, Vincent; Cavassini, Matthias; Klimkait, Thomas; Vernazza, Pietro L; Bernasconi, Enos; Furrer, Hansjakob; Günthard, Huldrych F; Kouyos, Roger (2016). Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland. Scientific Reports, 6(27580), p. 27580. Nature Publishing Group 10.1038/srep27580
Furrer, Hansjakob (2016). Opportunistic Diseases During HIV Infection - Things Aren′t What They Used to Be, or Are They? Journal of infectious diseases, 214(6), pp. 830-831. Oxford University Press 10.1093/infdis/jiw086
Darling, Katharine Ea; Hachfeld, Anna; Cavassini, Matthias; Kirk, Ole; Furrer, Hansjakob; Wandeler, Gilles (2016). Late presentation to HIV care despite good access to health services: current epidemiological trends and how to do better. Swiss medical weekly, 146(w14348), w14348. EMH Schweizerischer Ärzteverlag 10.4414/smw.2016.14348
Ramírez-Mena, Adrià; Glass, Tracy R.; Winter, Annja; Kimera, Namvua; Ntamatungiro, Alex; Hatz, Christoph; Tanner, Marcel; Battegay, Manuel; Furrer, Hansjakob; Wandeler, Gilles; Letang, Emilio (2016). Prevalence and Outcomes of Hepatitis B Coinfection and Associated Liver Disease Among Antiretroviral Therapy-Naive Individuals in a Rural Tanzanian Human Immunodeficiency Virus Cohort. Open Forum Infectious Diseases, 3(3), ofw162. Oxford University Press 10.1093/ofid/ofw162
Pires, João; Kuenzli, Esther; Kasraian Fard, Sara; Tinguely, Regula; Furrer, Hansjakob; Hilty, Markus; Hatz, Christoph; Endimiani, Andrea (2016). Polyclonal Intestinal Colonization with Extended-Spectrum Cephalosporin-Resistant Enterobacteriaceae upon Traveling to India. Frontiers in Microbiology, 7(1069), p. 1069. Frontiers 10.3389/fmicb.2016.01069
Nemeth, Johannes; Bernasconi, Enos; Heininger, Ulrich; Abbas, Mohamed; Nadal, David; Strahm, Carol; Erb, Stefan; Zimmerli, Stefan; Furrer, Hansjakob; Delaloye, Julie; Kuntzer, Thierry; Altpeter, Ekkehard; Sturzenegger, Matthias; Weber, Rainer (2016). Update of the Swiss guidelines on post-treatment Lyme disease syndrome. Swiss medical weekly, 146(w14353), w14353. EMH Schweizerischer Ärzteverlag 10.4414/smw.2016.14353
Ebner, Lukas; Walti, Laura Naëmi; Rauch, Andri; Furrer, Hansjakob; Cusini, Alexia; Meyer, Andreas M J; Weiler, Stefan; Huynh-Do, Uyen; Heverhagen, Johannes; Arampatzis, Spyridon; Christe, Andreas (2016). Clinical Course, Radiological Manifestations, and Outcome of Pneumocystis jirovecii Pneumonia in HIV Patients and Renal Transplant Recipients. PLoS ONE, 11(11), e0164320. Public Library of Science 10.1371/journal.pone.0164320
Hachfeld, Anna; Ledergerber, Bruno; Darling, Katharine; Weber, Rainer; Calmy, Alexandra; Battegay, Manuel; Sugimoto, Kiyoshi; Di Benedetto, Caroline; Fux, Christoph A; Tarr, Philip E; Kouyos, Roger; Furrer, Hansjakob; Wandeler, Gilles (2015). Reasons for late presentation to HIV care in Switzerland. Journal of the International AIDS Society, 18(1), p. 20317. BioMed Central 10.7448/IAS.18.1.20317
Ryom, L; Boesecke, C; Gisler, Valentin; Manzardo, C; Rockstroh, J K; Puoti, M; Furrer, Hansjakob; Miro, J M; Gatell, J M; Pozniak, A; Behrens, G; Battegay, M; Lundgren, J D (2015). Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons. HIV medicine, 17(2), pp. 83-88. Blackwell Science 10.1111/hiv.12322
Glass, Tracy R; Sterne, Jonathan A C; Schneider, Marie-Paule; De Geest, Sabina; Nicca, Dunja; Furrer, Hansjakob; Günthard, Huldrych F; Bernasconi, Enos; Calmy, Alexandra; Rickenbach, Martin; Battegay, Manuel; Bucher, Heiner C (2015). Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality. AIDS, 29(16), pp. 2195-2200. Lippincott Williams & Wilkins 10.1097/QAD.0000000000000782
Faini, Diana; Maokola, Werner; Furrer, Hansjakob; Hatz, Christoph; Battegay, Manuel; Tanner, Marcel; Denning, David W; Letang, Emilio (2015). Burden of serious fungal infections in Tanzania. Mycoses, 58(S5), pp. 70-79. Wiley-Blackwell 10.1111/myc.12390
Kohler, Philipp; Schmidt, Axel J; Cavassini, Matthias; Furrer, Hansjakob; Calmy, Alexandra; Battegay, Manuel; Bernasconi, Enos; Ledergerber, Bruno; Vernazza, Pietro (2015). The HIV care cascade in Switzerland: reaching the UNAIDS/WHO targets for patients diagnosed with HIV. AIDS, 29(18), pp. 2509-2515. Lippincott Williams & Wilkins 10.1097/QAD.0000000000000878
Hasse, Barbara; Tarr, Philip E; Marques-Vidal, Pedro; Waeber, Gerard; Preisig, Martin; Mooser, Vincent; Valeri, Fabio; Djalali, Sima; Rauch, Andri; Bernasconi, Enos; Calmy, Alexandra; Cavassini, Matthias; Vernazza, Pietro; Battegay, Manuel; Weber, Rainer; Senn, Oliver; Vollenweider, Peter; Ledergerber, Bruno; Aubert, V; Barth, J; ... (2015). Strong Impact of Smoking on Multimorbidity and Cardiovascular Risk Among Human Immunodeficiency Virus-Infected Individuals in Comparison With the General Population. Open Forum Infectious Diseases, 2(3), ofv108. Oxford University Press 10.1093/ofid/ofv108
Lodi, Sara; Phillips, Andrew; Logan, Roger; Olson, Ashley; Costagliola, Dominique; Abgrall, Sophie; van Sighem, Ard; Reiss, Peter; Miró, José M; Ferrer, Elena; Justice, Amy; Gandhi, Neel; Bucher, Heiner C; Furrer, Hansjakob; Moreno, Santiago; Monge, Susana; Touloumi, Giota; Pantazis, Nikos; Sterne, Jonathan; Young, Jessica G; ... (2015). Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study. The Lancet HIV, 2(8), e335-e343. Elsevier 10.1016/S2352-3018(15)00108-3
Schaerer, V; Haubitz, Sebastian; Kovari, H; Ledergerber, B; Ambrosioni, J; Cavassini, M; Stoeckle, M; Schmid, P; Decosterd, L; Aouri, M; Böni, J; Günthard, H F; Furrer, Hansjakob; Metzner, K J; Fehr, J; Rauch, Andri (2015). Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake. HIV medicine, 16(10), pp. 599-607. Blackwell Science 10.1111/hiv.12269
Achhra, A C; Phillips, A; Emery, S; MacArthur, R D; Furrer, Hansjakob; De Wit, S; Losso, M; Law, M G (2015). Pre-therapy inflammation and coagulation activation and long-term CD4 count responses to the initiation of antiretroviral therapy. HIV medicine, 16(7), pp. 449-454. Blackwell Science 10.1111/hiv.12258
Mansfeld, M; Skrahina, A; Shepherd, L; Schultze, A; Panteleev, A M; Miller, R F; Miro, J M; Zeltina, I; Tetradov, S; Furrer, Hansjakob; Kirk, O; Grzeszczuk, A; Bolokadze, N; Matteelli, A; Post, F A; Lundgren, J D; Mocroft, A; Efsen, Amw; Pdlekareva, D N (2015). Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe. HIV medicine, 16(9), pp. 544-552. Blackwell Science 10.1111/hiv.12256
Kurmann, Rebekka; Weisstanner, Christian; Kardas, Piotr; Hirsch, Hans H; Wiest, Roland; Lämmle, Bernhard; Furrer, Hansjakob; Du Pasquier, Renaud; Bassetti, Claudio; Sturzenegger, Matthias; Krestel, Heinz Eric (2015). Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine. Journal of neurovirology, 21(6), pp. 694-701. Springer 10.1007/s13365-015-0340-4
Hirzel, Cédric; Guilarte, Yuvia N; Hirzberger, Lea; Furrer, Hansjakob; Marschall, Jonas; Endimiani, Andrea (2015). In vitro susceptibility of Aerococcus urinae isolates to antibiotics used for uncomplicated urinary tract infection. Journal of infection, 71(3), pp. 395-397. Elsevier 10.1016/j.jinf.2015.04.020
Bruyand, Mathias; Ryom, Lene; Shepherd, Leah; Fatkenheuer, Gerd; Grulich, Andrew; Reiss, Peter; de Wit, Stéphane; D'Arminio Monforte, Antonella; Furrer, Hansjakob; Pradier, Christian; Lundgren, Jens; Sabin, Caroline (2015). Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the d: a: d study. Journal of acquired immune deficiency syndromes JAIDS, 68(5), pp. 568-577. Lippincott Williams & Wilkins 10.1097/QAI.0000000000000523
Ewald, Hannah; Raatz, Heike; Boscacci, Remy; Furrer, Hansjakob; Bucher, Heiner C; Briel, Matthias (2015). Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection. Cochrane database of systematic reviews, 4(CD006150), CD006150. WileyInterscience 10.1002/14651858.CD006150.pub2
Achhra, Ac; Mocroft, A; Ross, Mj; Ryom, L; Lucas, Gm; Furrer, Hansjakob; Neuhaus, J; Somboonwit, C; Kelly, M; Gatell, Jm; Wyatt, Cm (2015). Kidney disease in antiretroviral-naïve HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV medicine, 16(Suppl1), pp. 55-63. Blackwell Science 10.1111/hiv.12234
Kouyos, Roger D; Hasse, Barbara; Calmy, Alexandra; Cavassini, Matthias; Furrer, Hansjakob; Stöckle, Marcel; Vernazza, Pietro L; Bernasconi, Enos; Weber, Rainer; Günthard, Huldrych F; Aubert, V; Battegay, M; Bernasconi, E; Böni, J; Bucher, H C; Burton-Jeangros, C; Calmy, A; Cavassini, M; Dollenmaier, G; Egger, M; ... (2015). Increases in Condomless Sex in the Swiss HIV Cohort Study. Open Forum Infectious Diseases, 2(2), ofv077. Oxford University Press 10.1093/ofid/ofv077
Letang, Emilio; Müller, Matthias C; Ntamatungiro, Alex J; Kimera, Namvua; Faini, Diana; Furrer, Hansjakob; Battegay, Manuel; Tanner, Marcel; Hatz, Christoph; Boulware, David R; Glass, Tracy R (2015). Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality. Open Forum Infectious Diseases, 2(2), ofv046. Oxford University Press 10.1093/ofid/ofv046
Schlagenhauf, Patricia; Hatz, Christoph; Behrens, Ron; Visser, Leo; Funk, Maia; Holzer, Benedikt; Beck, Bernhard; Bourquin, Cathérine; Etter, Hermann; Furrer, Hansjakob; Genton, Blaise; Landry, Pierre; Chappuis, Francois; Loutan, Louis; Stössel, Ulrich; Jeschko, Eva; Rossanese, Andrea; Nothdurft, Hans Dieter (2015). Mefloquine at the crossroads? Implications for malaria chemoprophylaxis in Europe. Travel medicine and infectious disease, 13(2), pp. 192-196. Elsevier 10.1016/j.tmaid.2015.03.010
Wandeler, Gilles; Schlauri, Marion; Jaquier, Marie-Eve; Rohrbach, Janine; Metzner, Karin J; Fehr, Jan; Ambrosioni, Juan; Cavassini, Matthias; Stöckle, Marcel; Schmid, Patrick; Bernasconi, Enos; Keiser, Olivia; Salazar-Vizcaya, Luisa; Furrer, Hansjakob; Rauch, Andri (2015). Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013. Open Forum Infectious Diseases, 2(1), ofv026. Oxford University Press 10.1093/ofid/ofv026
Cozzi-Lepri, Alessandro; Noguera-Julian, Marc; Di Giallonardo, Francesca; Schuurman, Rob; Däumer, Martin; Aitken, Sue; Ceccherini-Silberstein, Francesca; D'Arminio Monforte, Antonella; Geretti, Anna Maria; Booth, Clare L; Kaiser, Rolf; Michalik, Claudia; Jansen, Klaus; Masquelier, Bernard; Bellecave, Pantxika; Kouyos, Roger D; Castro, Erika; Furrer, Hansjakob; Schultze, Anna; Günthard, Huldrych F; ... (2015). Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing. Journal of antimicrobial chemotherapy, 70(3), pp. 930-940. Oxford University Press 10.1093/jac/dku426
Stucki, David; Ballif, Marie; Bodmer, Thomas; Coscolla, Mireia; Maurer, Anne-Marie; Droz, Sara Christine; Butz, Christa; Borrell, Sonia; Längle, Christel; Feldmann, Julia; Furrer, Hansjakob; Mordasini, Carlo; Helbling, Peter; Rieder, Hans L; Egger, Matthias; Gagneux, Sébastien; Fenner, Lukas (2015). Tracking a tuberculosis outbreak over 21 years: strain-specific single nucleotide polymorphism-typing combined with targeted whole genome sequencing. Journal of infectious diseases, 211(8), pp. 1306-1316. Oxford University Press 10.1093/infdis/jiu601
Yang, Wan-Lin; Kouyos, Roger; Scherrer, Alexandra U; Böni, Jürg; Shah, Cyril; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Furrer, Hansjakob; Battegay, Manuel; Cavassini, Matthias; Bernasconi, Enos; Vernazza, Pietro; Held, Leonhard; Ledergerber, Bruno; Günthard, Huldrych F (2015). Assessing the paradox between transmitted and acquired HIV-1 drug resistance in the Swiss HIV Cohort Study from 1998 to 2012. Journal of infectious diseases, 212(1), pp. 28-38. Oxford University Press 10.1093/infdis/jiv012
Haraka, Frederick; Glass, Tracy R; Sikalengo, George; Gamell, Anna; Ntamatungiro, Alex; Hatz, Christoph; Tanner, Marcel; Furrer, Hansjakob; Battegay, Manuel; Letang, Emilio (2015). A Bundle of Services Increased Ascertainment of Tuberculosis among HIV-Infected Individuals Enrolled in a HIV Cohort in Rural Sub-Saharan Africa. PLoS ONE, 10(4), e0123275. Public Library of Science 10.1371/journal.pone.0123275
Efsen, Anne Marie W; Schultze, Anna; Post, Frank A; Panteleev, Alexander; Furrer, Hansjakob; Miller, Robert F; Losso, Marcelo H; Toibaro, Javier; Skrahin, Aliaksandr; Miro, Jose M; Caylà, Joan A; Girardi, Enrico; Bruyand, Mathias; Obel, Niels; Podlekareva, Daria N; Lundgren, Jens D; Mocroft, Amanda; Kirk, Ole (2015). Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin America. PLoS ONE, 10(12), e0145380. Public Library of Science 10.1371/journal.pone.0145380
Furrer, Hansjakob (2015). Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013. Euro surveillance, 20(47) Institut de Veille Sanitaire 10.2807/1560-7917.ES.2015.20.47.30070
Hauser, Christoph; Hirzberger, Lea; Unemo, Magnus; Furrer, Hansjakob; Endimiani, Andrea (2014). In vitro Activity of Fosfomycin Alone and in Combination with Ceftriaxone or Azithromycin Against Clinical Neisseria gonorrhoeae Isolates. Antimicrobial agents and chemotherapy, 59(3), pp. 1605-1611. American Society for Microbiology 10.1128/AAC.04536-14
Gisler, Valentin; Kraus, David; Nemeth, Johannes; Lecompte, Marthe Than; Merz, Laurent; Stoeckle, Marcel; Schmid, Patrick; Bernasconi, Enos; Weber, Rainer; Cavassini, Matthias; Calmy, Alexandra; Elzi, Luigia; Furrer, Hansjakob (2 November 2014). AIDS defining opportunistic infections in patients with high CD4 counts in the combination antiretroviral therapy (cART) era: things ain't what they used to be. Journal of the International AIDS Society, 17(Suppl 3), p. 19621. BioMed Central 10.7448/IAS.17.4.19621
Lupo, Agnese; Guilarte, Yuvia N; Droz, Sara Christine; Hirzel, Cédric; Furrer, Hansjakob; Endimiani, Andrea (2014). In vitro activity of clinically implemented β-lactams against Aerococcus urinae: presence of non-susceptible isolates in Switzerland. The new microbiologica, 37(4), pp. 563-566. Edizioni Medico Scientifiche
Castillo, Jorge J; Bower, Mark; Brühlmann, Jérémy; Novak, Urban; Furrer, Hansjakob; Tanaka, Paula Y; Besson, Caroline; Montoto, Silvia; Cwynarski, Kate; Abramson, Jeremy S; Dalia, Samir; Bibas, Michele; Connors, Joseph M; Furman, Michael; Nguyen, Minh-Ly; Cooley, Timothy P; Beltran, Brady E; Collins, Jaime A; Vose, Julie M; Xicoy, Blanca; ... (2014). Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: A multi-institutional retrospective study. Cancer research, 121(3), pp. 423-431. American Association for Cancer Research AACR 10.1002/cncr.29066
Bibert, Stéphanie; Wojtowicz, Agnieszka; Taffé, Patrick; Manuel, Oriol; Bernasconi, Enos; Furrer, Hansjakob; Günthard, Huldrych F; Hoffmann, Matthias; Kaiser, Laurent; Osthoff, Michael; Cavassini, Matthias; Bochud, Pierre-Yves (2014). The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients. AIDS, 28(13), pp. 1885-1889. Lippincott Williams & Wilkins 10.1097/QAD.0000000000000379
Hasse, Barbara; Bernasconi, Enos; Furrer, Hansjakob; Eyer, Myriam Marcelle; Kovari, Helen (2014). HIV und Komorbidität. Therapeutische Umschau, 71(8), pp. 483-489. Huber 10.1024/0040-5930/a000541
Staehelin, Cornelia Johanna; Elzi, Luigia; Weber, Rainer; Furrer, Hansjakob (2014). Therapie und Prävention von opportunistischen Infektionen. Therapeutische Umschau, 71(8), pp. 475-482. Huber 10.1024/0040-5930/a000540
von Braun, Amrei; Furrer, Hansjakob; Battegay, Manuel; Calmy, Alexandra; Cavassini, Matthias; Vernazza, Pietro; Bernasconi, Enos; Weber, Rainer; Günthard, Huldrych F (2014). Antiretrovirale Therapie. Therapeutische Umschau, 71(8), pp. 461-468. Huber 10.1024/0040-5930/a000538
Metzner, Karin J.; Scherrer, Alexandra U.; Von Wyl, Viktor; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Furrer, Hansjakob; Hirsch, Hans H.; Vernazza, Pietro L.; Cavassini, Matthias; Calmy, Alexandra; Bernasconi, Enos; Weber, Rainer; Günthard, Huldrych F. (2014). Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients. AIDS, 28(15), pp. 2231-2239. Lippincott Williams & Wilkins 10.1097/QAD.0000000000000397
Boillat-Blanco, Noémie; Darling, Katharine Ea; Schoni-Affolter, Franziska; Vuichard, Danielle; Rougemont, Mathieu; Fulchini, Rosamaria; Bernasconi, Enos; Aouri, Manel; Clerc, Olivier; Furrer, Hansjakob; Günthard, Huldrych F; Cavassini, Matthias (2014). Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study. Antiviral therapy, 20(2), pp. 165-175. International Medical Press 10.3851/IMP2815
Seiffert, Salome Nadja; Marschall, Jonas; Perreten, Vincent; Carattoli, Alessandra; Furrer, Hansjakob; Endimiani, Andrea (2014). Emergence of Klebsiella pneumoniae co-producing NDM-1, OXA-48, CTX-M-15, CMY-16, QnrA and ArmA in Switzerland. International journal of antimicrobial agents, 44(3), pp. 260-262. Elsevier 10.1016/j.ijantimicag.2014.05.008
Schäfer, J.; Young, J.; Bernasconi, E.; Ledergerber, B.; Nicca, D.; Calmy, A.; Cavassini, M.; Furrer, H.; Battegay, M.; Bucher, H. C. (2014). Predicting smoking cessation and its relapse in HIV-infected patients: the Swiss HIV Cohort Study. HIV medicine, 16(1), pp. 3-14. Blackwell Science 10.1111/hiv.12165
Young, Jim; Wang, Qing; Fux, Christoph Andreas; Bernasconi, Enos; Furrer, Hansjakob; Vernazza, Pietro; Calmy, A.; Cavassini, Matthias; Weber, Rainer; Battegay, Manuel; Bucher, Heiner C; Swiss HIV Cohort, Study (2014). The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovir. HIV medicine, 15(8), pp. 505-510. Blackwell Science 10.1111/hiv.12149
Hasse, Barbara; Walker, A Sarah; Fehr, Jan; Furrer, Hansjakob; Hoffmann, Matthias; Battegay, Manuel; Calmy, Alexandra; Fellay, Jacques; Di Benedetto, Caroline; Weber, Rainer; Ledergerber, Bruno; Swiss HIV Cohort, Study (2014). Cotrimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study. Antimicrobial agents and chemotherapy, 58(4), pp. 2363-2368. American Society for Microbiology 10.1128/AAC.01868-13
Braun, Julia; Held, Leonhard; Ledergerber, Bruno; Egger, M; Furrer, H; Keiser, O; Rauch, Andri; Schöni-Affolter, F; Swiss HIV Cohort Study, (2014). Accounting for baseline differences and measurement error in the analysis of change over time. Statistics in medicine, 33(1), pp. 2-16. Wiley-Blackwell 10.1002/sim.5910
Podlekareva, Daria N; Panteleev, Alexander M; Grint, Daniel; Post, Frank A; Miro, Jose M; Bruyand, Mathias; Furrer, Hansjakob; Obel, Niels; Girardi, Enrico; Vasilenko, Anna; Losso, Marcelo H; Arenas-Pinto, Alejandro; Caylá, Joan; Rakhmanova, Aza; Zeltina, Indra; Werlinrud, Anne Marie; Lundgren, Jens D; Mocroft, Amanda; Kirk, Ole; Egger, M; ... (2014). Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe. European respiratory journal, 43(1), pp. 166-77. European Respiratory Society 10.1183/09031936.00138712
Drescher, Sara M; von Wyl, Viktor; Yang, Wan-Lin; Böni, Jürg; Yerly, Sabine; Shah, Cyril; Aubert, Vincent; Klimkait, Thomas; Taffé, Patrick; Furrer, Hansjakob; Battegay, Manuel; Ambrosioni, Juan; Cavassini, Matthias; Bernasconi, Enos; Vernazza, Pietro L; Ledergerber, Bruno; Günthard, Huldrych F; Kouyos, Roger D; Egger, M; Keiser, O; ... (2014). Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study. Clinical infectious diseases, 58(2), pp. 285-94. Oxford University Press 10.1093/cid/cit694
Kouyos, Roger D; Rauch, Andri; Böni, Jürg; Yerly, Sabine; Shah, Cyril; Aubert, Vincent; Klimkait, Thomas; Kovari, Helen; Calmy, Alexandra; Cavassini, Matthias; Battegay, Manuel; Vernazza, Pietro L; Bernasconi, Enos; Ledergerber, Bruno; Günthard, Huldrych F; Egger, Matthias; Furrer, Hansjakob; Keiser, Olivia; Schöni-Affolter, Franziska and Swiss HIV Cohort, Study (2014). Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV. International journal of epidemiology, 43(3), pp. 887-896. Oxford University Press 10.1093/ije/dyt276
Endimiani, Andrea; Guilarte, Yuvia; Tinguely, Regula; Hirzberger, Lea; Selvini, Sylvia; Lupo, Agnese; Hauser, Christoph; Furrer, Hansjakob (2014). Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998–2012): emergence of multidrug-resistant clones less susceptible to cephalosporins. BMC infectious diseases, 14(1), pp. 106-116. BioMed Central 10.1186/1471-2334-14-106
Mocroft, Amanda; Ryom, Lene; Reiss, Peter; Furrer, Hansjakob; D'Arminio Monforte, Antonella; Gatell, José; de Wit, Stephane; Beniowski, Marek; Lundgren, Jens D; Kirk, Ole (2014). A comparison of estimated glomerular filtration rates using Cockcroft−Gault and the Chronic Kidney Disease Epidemiology Collaboration estimating equations in HIV infection. HIV medicine, 15(3), pp. 144-152. Blackwell Science 10.1111/hiv.12095
Wang, Qing; Young, Jim; Bernasconi, Enos; Vernazza, Pietro; Calmy, Alexandra; Cavassini, Matthias; Furrer, Hansjakob; Fehr, Jan; Bucher, Heiner C; Battegay, Manuel; Swiss Hiv Cohort Study, SHCS (2014). Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone. HIV clinical trials, 15(3), pp. 92-103. Thomas Land Publishers 10.1310/hct1503-92
Kuenzli, Esther; Jaeger, Veronika K; Frei, Reno; Neumayr, Andreas; DeCrom, Susan; Haller, Sabine; Blum, Johannes; Widmer, Andreas F; Furrer, Hansjakob; Battegay, Manuel; Endimiani, Andrea; Hatz, Christoph (2014). High colonization rates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in Swiss Travellers to South Asia- a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors. BMC infectious diseases, 14(528), p. 528. BioMed Central 10.1186/1471-2334-14-528
Sprenger, Katharina; Evison, John Marc; Zwahlen, Marcel; Vogt, Cedric M; Elzi, Maria Verena; Hauser, Christoph; Furrer, Hansjakob; Low, Nicola (2014). Sexually transmitted infections in HIV-infected people in Switzerland: cross-sectional study. PeerJ, 2, e537. PeerJ 10.7717/peerj.537
Esposito, Douglas H; Stich, August; Epelboin, Loïc; Malvy, Denis; Han, Pauline V; Bottieau, Emmanuel; da Silva, Alexandre; Zanger, Philipp; Slesak, Günther; van Genderen, Perry J J; Rosenthal, Benjamin M; Cramer, Jakob P; Visser, Leo G; Muñoz, José; Drew, Clifton P; Goldsmith, Cynthia S; Steiner, Florian; Wagner, Noémie; Grobusch, Martin P; Plier, D Adam; ... (2014). Acute muscular sarcocystosis: an international investigation among ill travelers returning from tioman island, malaysia, 2011-2012. Clinical infectious diseases, 59(10), pp. 1401-1410. Oxford University Press 10.1093/cid/ciu622
Mocroft, Amanda; Ryom, Lene; Lapadula, Giuseppe; Reiss, Peter; Blaxhult, Anders; Furrer, Hansjakob; Kutsyna, Galyna; Gatell, Jose; Begovac, Josep; Kirk, Ole; Lundgren, Jens (2014). The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe. Journal of the International AIDS Society, 17(4,Suppl3), p. 19561. BioMed Central 10.7448/IAS.17.4.19561
Efsen, Anne Marie; Schultze, Anna; Post, Frank; Panteleev, Alexander; Furrer, Hansjakob; Miller, Robert; Skrahin, Aliaksandr; Losso, Marcelo H; Toibaro, Javier; Girardi, Enrico; Miro, José; Bruyand, Mathias; Obel, Niels; Caylá, Joan; Podlekareva, Daria; Lundgren, Jens; Mocroft, Amanda; Kirk, Ole (2014). Major challenges in clinical management of TB/HIV co-infected patients in Eastern Europe compared with Western Europe and Latin America. Journal of the International AIDS Society, 17(4,Suppl3), p. 19505. BioMed Central 10.7448/IAS.17.4.19505
Sprenger, Katharina; Furrer, Hansjakob (2014). Chameleons everywhere. BMJ case reports, 2014 BMJ Publishing Group 10.1136/bcr-2014-205608
Hasse, B.; Iff, M.; Ledergerber, B.; Calmy, A.; Schmid, P.; Hauser, Christoph; Cavassini, M.; Bernasconi, E.; Marzolini, C.; Tarr, P. E.; Swiss HIV, Cohort Study; Furrer, Hansjakob; Gorgievski, Meri; Rauch, Andri; Stähelin, Cornelia Johanna (2014). Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study. Open Forum Infectious Diseases, 1(2), ofu040. Oxford University Press 10.1093/ofid/ofu040
von Wyl, Viktor; Klimkait, Thomas; Yerly, Sabine; Nicca, Dunja; Furrer, Hansjakob; Cavassini, Matthias; Calmy, Alexandra; Bernasconi, Enos; Böni, Jürg; Aubert, Vincent; Günthard, Huldrych F.; Bucher, Heiner C.; Glass, Tracy R.; Wainberg, Mark (2013). Adherence as a Predictor of the Development of Class-Specific Resistance Mutations: The Swiss HIV Cohort Study. PLoS ONE, 8(10), e77691. Public Library of Science 10.1371/journal.pone.0077691
Mocroft, Amanda; Lundgren, Jens D.; Sabin, Miriam Lewis; d'Arminio Monforte, Antonella; Brockmeyer, Norbert; Casabona, Jordi; Castagna, Antonella; Costagliola, Dominique; Dabis, Francois; De Wit, Stéphane; Fätkenheuer, Gerd; Furrer, Hansjakob; Johnson, Anne M.; Lazanas, Marios K.; Leport, Catherine; Moreno, Santiago; Obel, Niels; Post, Frank A.; Reekie, Joanne; Reiss, Peter; ... (2013). Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS medicine, 10(9), e1001510. Public Library of Science 10.1371/journal.pmed.1001510
Beerenwinkel, Niko; Montazeri, Hesam; Schuhmacher, Heike; Knupfer, Patrick; von Wyl, Viktor; Furrer, Hansjakob; Battegay, Manuel; Hirschel, Bernard; Cavassini, Matthias; Vernazza, Pietro; Bernasconi, Enos; Yerly, Sabine; Böni, Jürg; Klimkait, Thomas; Cellerai, Cristina; Günthard, Huldrych F.; Vandamme, Anne-Mieke (2013). The Individualized Genetic Barrier Predicts Treatment Response in a Large Cohort of HIV-1 Infected Patients. PLoS computational biology, 9(8), e1003203. Public Library of Science 10.1371/journal.pcbi.1003203
Tinguely, Regula; Seiffert, Salome Nadja; Furrer, Hansjakob; Perreten, Vincent; Droz, Sara Christine; Endimiani, Andrea (2013). Emergence of extensively drug-resistant Haemophilus parainfluenzae in Switzerland. Antimicrobial agents and chemotherapy, 57(6), pp. 2867-2869. American Society for Microbiology 10.1128/AAC.00221-13
Furrer, Hansjakob; Staehelin, Cornelia Johanna; Landolt, Rebecca; Hatz, Christoph (2013). Reisemedizinische Beratung – mehr als eine Impfcheckliste. Therapeutische Umschau, 70(6), pp. 309-312. Huber 10.1024/0040-5930/a000408
Cotter, Aoife G.; Vrouenraets, Saskia M. E.; Brady, Jennifer J.; Wit, Ferdinand W.; Fux, Christoph A.; Furrer, Hansjakob; Brinkman, Kees; Sabin, Caroline A.; Reiss, Peter; Mallon, Patrick W. G. (2013). Impact of Switching From Zidovudine to Tenofovir Disoproxil Fumarate on Bone Mineral Density and Markers of Bone Metabolism in Virologically Suppressed HIV-1 Infected Patients; A Substudy of the PREPARE Study. Journal of clinical endocrinology and metabolism, 98(4), pp. 1659-1666. Endocrine Society 10.1210/jc.2012-3686
Fenner, Lukas; Egger, Matthias; Bodmer, Thomas; Furrer, Hansjakob; Ballif, Marie; Battegay, Manuel; Helbling, Peter; Fehr, Jan; Gsponer, Thomas; Rieder, Hans L.; Zwahlen, Marcel; Hoffmann, Matthias; Bernasconi, Enos; Cavassini, Matthias; Calmy, Alexandra; Dolina, Marisa; Frei, Reno; Janssens, Jean-Paul; Borrell, Sonia; Stucki, David; ... (2013). HIV infection disrupts the sympatric host-pathogen relationship in human tuberculosis. PLoS genetics, 9(3), e1003318. Public Library of Science 10.1371/journal.pgen.1003318
Lubomirov, Rubin; Arab-Alameddine, Mona; Rotger, Margalida; Fayet-Mello, Aurélie; Martinez, Raquel; Guidi, Monia; di Iulio, Julia; Cavassini, Matthias; Günthard, Huldrych F.; Furrer, Hansjakob; Marzolini, Catia; Bernasconi, Enos; Calmy, Alexandra; Buclin, Thierry; Decosterd, Laurent A.; Csajka, Chantal; Telenti, Amalio (2013). Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals. Pharmacogenetics and genomics, 23(1), pp. 9-18. Lippincott Williams & Wilkins 10.1097/FPC.0b013e32835ade82
Wandeler, Gilles; Gsponer, Thomas; Bihl, Florian; Bernasconi, Enos; Cavassini, Matthias; Kovari, Helen; Schmid, Patrick; Battegay, Manuel; Calmy, Alexandra; Egger, Matthias; Furrer, Hansjakob; Rauch, Andri (2013). Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study. Journal of infectious diseases, 208(9), pp. 1454-1458. Cary, N.C.: Oxford University Press 10.1093/infdis/jit351
Pfortmüller, Carmen; Efeoglou, Anastasios; Furrer, Hansjakob; Exadaktylos, Aristomenis (2013). Dog Bite Injuries: Primary and Secondary Emergency Department Presentations-A Retrospective Cohort Study. The Scientific World Journal, 2013(393176), pp. 1-6. Hindawi Publishing Corporation 10.1155/2013/393176
Worm, Signe W; Bower, Mark; Reiss, Peter; Bonnet, Fabrice; Law, Matthew; Fätkenheuer, Gerd; d’Arminio Monforte, Antonella; Abrams, Donald I; Grulich, Andrew; Fontas, Eric; Kirk, Ole; Furrer, Hansjakob; Wit, Stephane; Phillips, Andrew; Lundgren, Jens D; Sabin, Caroline A (2013). Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: a cohort study. BMC infectious diseases, 13(471), p. 471. BioMed Central 10.1186/1471-2334-13-471
Rohrbach, Janine; Stickel, Felix; Schmid, Patrick; Thormann, Wolfgang; Kovari, Helen; Scherrer, Alexandra; Günthard, Huldrych F.; Vuichard, Danielle; Cavassini, Matthias; Ambrosioni, Juan; Bernasconi, Enos; Furrer, Hansjakob; Rauch, Andri; Swiss HIV Cohort Study, The (2013). Changes in biomarkers of liver disease during successful combination antiretroviral therapy in HIV/HCV-coinfected individuals. Antiviral therapy, 19(2), pp. 149-159. International Medical Press 10.3851/IMP2686
Mocroft, A.; Furrer, H. J.; Miro, J. M.; Reiss, P; Mussini, C.; Kirk, O.; Abgrall, S.; Ayayi, S.; Bartmeyer, B.; Braun, D.; Castagna, A.; d'Arminio Monforte, A.; Gazzard, B.; Gutierrez, F.; Hurtado, I.; Jansen, K.; Meyer, L.; Munoz, P.; Obel, N.; Soler-Palacin, P.; ... (2013). The Incidence of AIDS-Defining Illnesses at a Current CD4 Count >=200 Cells/ L in the Post-Combination Antiretroviral Therapy Era. Clinical infectious diseases, 57(7), pp. 1038-1047. Oxford University Press 10.1093/cid/cit423
Metzner, K. J.; Scherrer, A. U.; Preiswerk, B.; Joos, B.; von Wyl, V.; Leemann, C.; Rieder, P.; Braun, D.; Grube, C.; Kuster, H.; Böni, J.; Yerly, S.; Klimkait, T.; Aubert, V.; Furrer, Hansjakob; Battegay, M.; Vernazza, P. L.; Cavassini, M.; Calmy, A.; Bernasconi, E.; ... (2013). Origin of Minority Drug-Resistant HIV-1 Variants in Primary HIV-1 Infection. Journal of infectious diseases, 208(7), pp. 1102-1112. Oxford University Press 10.1093/infdis/jit310
Lodi, Sara; del Amo, Julia; d'Arminio Monforte, Antonella; Abgrall, Sophie; Sabin, Caroline; Morrison, Charles; Furrer, Hansjakob; Muga, Roberto; Porter, Kholoud; Girardi, Enrico (2013). Risk of tuberculosis following HIV seroconversion in high-income countries. Thorax, 68(3), pp. 207-213. BMJ Publishing Group 10.1136/thoraxjnl-2012-201740
Podlekareva, D. N.; Grint, D.; Post, F. A.; Mocroft, A.; Panteleev, A. M.; Miller, R. F.; Miro, J. M.; Bruyand, M.; Furrer, H.; Riekstina, V.; Girardi, E.; Losso, M. H.; Caylá, J. A.; Malashenkov, E. A.; Obel, N.; Skrahina, A. M.; Lundgren, J. D.; Kirk, O. (2013). Health care index score and risk of death following tuberculosis diagnosis in HIV-positive patients. International journal of tuberculosis and lung disease, 17(2), pp. 198-206. International Union Against Tuberculosis and Lung Disease IUATLD 10.5588/ijtld.12.0224
Oertel, M. F.; Furrer, H.; Mull, M.; Krings, T.; Thorn, A. K.; Gilsbach, J. M.; Rohde, V. (2013). Results of surgical treatment for spinal intradural perimedullary arteriovenous fistulas. In: World Federation of Neurosurgical Societies World Congress. Seoul.
Fenner, Lukas; Egger, Matthias; Bodmer, Thomas; Altpeter, Ekkehardt; Zwahlen, Marcel; Jaton, Katia; Pfyffer, Gaby E; Borrell, Sonia; Dubuis, Olivier; Bruderer, Thomas; Siegrist, Hans H; Furrer, Hansjakob; Calmy, Alexandra; Fehr, Jan; Stalder, Jesica Mazza; Ninet, Béatrice; Böttger, Erik C; Gagneux, Sebastien; HIV Cohort Study, Swiss Molecular Epidemiol (2012). Effect of Mutation and Genetic Background on Drug Resistance in Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 56(6), pp. 3047-3053. Washington, D.C.: American Society for Microbiology 10.1128/AAC.06460-11
Fenner, Lukas; Gagneux, Sebastien; Helbling, Peter; Battegay, Manuel; Rieder, Hans L; Pfyffer, Gaby E; Zwahlen, Marcel; Furrer, Hansjakob; Siegrist, Hans H; Fehr, Jan; Dolina, Marisa; Calmy, Alexandra; Stucki, David; Jaton, Katia; Janssens, Jean-Paul; Stalder, Jesica Mazza; Bodmer, Thomas; Ninet, Beatrice; Böttger, Erik C; Egger, Matthias; ... (2012). Mycobacterium tuberculosis transmission in a country with low tuberculosis incidence: role of immigration and HIV infection. Journal of clinical microbiology, 50(2), pp. 388-395. Washington, D.C.: American Society for Microbiology 10.1128/JCM.05392-11
Staehelin, Cornelia; Keiser, Olivia; Calmy, Alexandra; Weber, Rainer; Elzi, Luigia; Cavassini, Matthias; Schmid, Patrick; Bernasconi, Enos; Furrer, Hansjakob; Swiss HIV Cohort Study, (2012). Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes JAIDS, 59(1), pp. 79-85. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1097/QAI.0b013e318236be70
Thierfelder, C; Weber, R; Elzi, L; Furrer, H; Cavassini, M; Calmy, A; Bernasconi, E; Gutmann, C; Ledergerber, B; Swiss HIV Cohort Study Group, (2012). Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study. HIV medicine, 13(2), pp. 118-26. Oxford: Blackwell Science 10.1111/j.1468-1293.2011.00949.x
von Wyl, Viktor; Yerly, Sabine; Böni, Jürg; Shah, Cyril; Cellerai, Cristina; Klimkait, Thomas; Battegay, Manuel; Bernasconi, Enos; Cavassini, Matthias; Furrer, Hansjakob; Hirschel, Bernard; Vernazza, Pietro L; Ledergerber, Bruno; Günthard, Huldrych F; Swiss HIV Cohort, Study (2012). Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations. Clinical infectious diseases, 54(1), pp. 131-40. Cary, N.C.: Oxford University Press 10.1093/cid/cir728
Wandeler, Gilles; Gsponer, Thomas; Bregenzer, Andrea; Günthard, Huldrych F; Clerc, Olivier; Calmy, Alexandra; Stöckle, Marcel; Bernasconi, Enos; Furrer, Hansjakob; Rauch, Andri; Swiss HIV Cohort, Study (2012). Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic. Clinical infectious diseases, 55(10), pp. 1408-16. Cary, N.C.: Oxford University Press 10.1093/cid/cis694
Wang, Qing; Young, Jim; Bernasconi, Enos; Cavassini, Matthias; Vernazza, Pietro; Hirschel, Bernard; Weber, Rainer; Furrer, Hansjakob; Stoeckle, Marcel; Bucher, Heiner C; Fux, Christoph Andreas; Swiss HIV, Cohort Study (2012). The prevalence of erectile dysfunction and its association with antiretroviral therapy in HIV-infected men: the Swiss HIV Cohort Study. Antiviral therapy, 18(3), pp. 337-344. London: International Medical Press 10.3851/IMP2372
Scherrer, Alexandra U.; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Furrer, Hansjakob; Calmy, Alexandra; Cavassini, Matthias; Elzi, Luigia; Vernazza, Pietro L.; Bernasconi, Enos; Ledergerber, Bruno; Günthard, Huldrych F.; Swiss HIV Cohort Study (SHCS), (2012). Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens. PLoS ONE, 7(11), e50307. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0050307
Weber, R; Ruppik, M; Rickenbach, M; Spoerri, A; Furrer, Hansjakob; Battegay, M; Cavassini, M; Calmy, A; Bernasconi, E; Schmid, P; Flepp, M; Kowalska, J; Ledergerber, B; Swiss HIV Cohort Study, (SHCS) (2012). Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV medicine, 14(4), pp. 195-207. Oxford: Blackwell Science 10.1111/j.1468-1293.2012.01051.x
Elzi, Luigia; Erb, Stefan; Furrer, Hansjakob; Ledergerber, Bruno; Cavassini, Matthias; Hirschel, Bernard; Vernazza, Pietro; Bernasconi, Enos; Weber, Rainer; Battegay, Manuel; Swiss HIV Cohort Study, (2012). Choice of Initial Combination Antiretroviral Therapy in Individuals With HIV Infection: Determinants and Outcomes. Archives of internal medicine, 172(17), pp. 1313-21. Chicago, Ill.: American Medical Association 10.1001/archinternmed.2012.3216
Scherrer, Alexandra U.; Ledergerber, Bruno; von Wyl, Viktor; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Cellerai, Cristina; Furrer, Hansjakob; Calmy, Alexandra; Cavassini, Matthias; Elzi, Luigia; Vernazza, Pietro L.; Bernasconi, Enos; Günthard, Huldrych F.; Swiss HIV Cohort Study, (2012). Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients. PLoS ONE, 7(6), e37983. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0037983
Vrouenraets, S M E; Wit, F W N M; Garcia, E Fernandez; Huber, M; Brinkman, K; Moyle, G; Domingo, P; Tarr, P E; Podzamczer, D; Ristola, M; Gatell, J M; Livrozet, J M; Furrer, H; Reiss, P; PREPARE Study Group, (2012). Longer prior exposure to zidovudine/lamivudine-containing combination antiretroviral therapy, age, and male gender are each associated with reduced subcutaneous adipose tissue. HIV clinical trials, 13(2), pp. 103-10. St. Louis, Mo.: Thomas Land Publishers
Opportunistic Infections Project Team of the Collaboration of Ob, ; Young, Jim; Psichogiou, Mina; Meyer, Laurence; Ayayi, Sylvie; Grabar, Sophie; Raffi, Francois; Reiss, Peter; Gazzard, Brian; Sharland, Mike; Gutierrez, Félix; Obel, Niels; Kirk, Ole; Miro, José M; Furrer, Hansjakob; Castagna, Antonella; De Wit, Stéphane; Muñoz, Josefa; Kjaer, Jesper; Grarup, Jesper; ... (2012). CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. PLoS medicine, 9(3), e1001194. San Francisco, Calif.: Public Library of Science 10.1371/journal.pmed.1001194
Vrouenraets, Saskia M E; Fux, Christoph A; Wit, Ferdinand W N M; Garcia, Evian Fernandez; Brinkman, Kees; Hoek, Frans J; van Straalen, Jan P; Furrer, Hansjakob; Krediet, Ray T; Reiss, Peter; Prepare Study Group, (2012). A comparison of measured and estimated glomerular filtration rate in successfully treated HIV-patients with preserved renal function. Clinical nephrology, 77(4), pp. 311-20. München-Deisenhofen: Dustri-Verlag 10.5414/CN107214
Young, Jim; Schäfer, Juliane; Fux, Christoph A; Furrer, Hansjakob; Bernasconi, Enos; Vernazza, Pietro; Calmy, Alexandra; Cavassini, Matthias; Weber, Rainer; Battegay, Manuel; Bucher, Heiner C; Swiss HIV Cohort Study, (2012). Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir. AIDS, 26(5), pp. 567-75. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/QAD.0b013e32834f337c
Lubomirov, Rubin; Colombo, Sara; di Iulio, Julia; Ledergerber, Bruno; Martinez, Raquel; Cavassini, Matthias; Hirschel, Bernard; Bernasconi, Enos; Elzi, Luigia; Vernazza, Pietro; Furrer, Hansjakob; Günthard, Huldrych F; Telenti, Amalio; Swiss HIV Cohort Study, (2011). Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study. Journal of infectious diseases, 203(2), pp. 246-57. Cary, N.C.: Oxford University Press 10.1093/infdis/jiq043
Ledergerber, B; Cavassini, M; Battegay, M; Bernasconi, E; Vernazza, P; Hirschel, B; Furrer, H; Rickenbach, M; Weber, R; Swiss HIV Cohort Study (SHCS), (2011). Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study. HIV medicine, 12(5), pp. 279-88. Oxford: Blackwell Science 10.1111/j.1468-1293.2010.00880.x
Wandeler, Gilles; Keiser, Olivia; Hirschel, Bernard; Günthard, Huldrych F; Bernasconi, Enos; Battegay, Manuel; Clerc, Olivier; Vernazza, Pietro L; Furrer, Hansjakob; Swiss HIV, Cohort Study (2011). A comparison of initial antiretroviral therapy in the Swiss HIV Cohort Study and the recommendations of the International AIDS Society-USA. PLoS ONE, 6(12), e27903. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0027903
Wandeler, Gilles; Furrer, Hansjakob; Rauch, Andri (2011). Sustained virological response to a raltegravir-containing salvage therapy in an HIV-2-infected patient. AIDS, 25(18), pp. 2306-2308. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/QAD.0b013e32834cdb89
Elzi, Luigia; Steffen, Ingrid; Furrer, Hansjakob; Fehr, Jan; Cavassini, Matthias; Hirschel, Bernard; Hoffmann, Matthias; Bernasconi, Enos; Bassetti, Stefano; Battegay, Manuel (2011). Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection. BMC infectious diseases, 11, p. 319. London: BioMed Central 10.1186/1471-2334-11-319
Hasse, Barbara; Ledergerber, Bruno; Furrer, Hansjakob; Battegay, Manuel; Hirschel, Bernhard; Cavassini, Matthias; Bertisch, Barbara; Bernasconi, Enos; Weber, Rainer; Swiss HIV Cohort, Study (2011). Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clinical infectious diseases, 53(11), pp. 1130-9. Cary, N.C.: Oxford University Press 10.1093/cid/cir626
Vrouenraets, Saskia M E; Fux, Christoph A; Wit, Ferdinand W N M; Garcia, Evian Fernandez; Furrer, Hansjakob; Brinkman, Kees; Hoek, Frans J; Abeling, Nico G G M; Krediet, Ray T; Reiss, Peter; Prepare Study Group, (2011). Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity. AIDS, 25(17), pp. 2149-55. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/QAD.0b013e32834bba87
Marzolini, Catia; Back, David; Weber, Rainer; Furrer, Hansjakob; Cavassini, Matthias; Calmy, Alexandra; Vernazza, Pietro; Bernasconi, Enos; Khoo, Saye; Battegay, Manuel; Elzi, Luigia; Swiss HIV Cohort Study, Members (2011). Ageing with HIV: medication use and risk for potential drug-drug interactions. Journal of antimicrobial chemotherapy, 66(9), pp. 2107-11. Oxford: Oxford University Press 10.1093/jac/dkr248
Mossdorf, Erik; Stoeckle, Marcel; Mwaigomole, Emmanuel G; Chiweka, Evarist; Kibatala, Patience L; Geubbels, Eveline; Urassa, Honoraty; Abdulla, Salim; Elzi, Luigia; Tanner, Marcel; Furrer, Hansjakob; Hatz, Christoph; Battegay, Manuel (2011). Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition. BMC infectious diseases, 11, p. 98. London: BioMed Central 10.1186/1471-2334-11-98
Buclin, Thierry; Telenti, Amalio; Perera, Rafael; Csajka, Chantal; Furrer, Hansjakob; Aronson, Jeffrey K.; Glasziou, Paul P. (2011). Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therapy. PLoS ONE, 6(4), e18578. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0018578
Fux, Christoph A; Baumann, Sandra; Furrer, Hansjakob; Mueller, Nicolas J (2011). Is lower serum 25-hydroxy vitamin D associated with efavirenz or the non-nucleoside reverse transcriptase inhibitor class? AIDS, 25(6), pp. 876-8. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/QAD.0b013e32834544af
di Iulio, Julia; Ciuffi, Angela; Fitzmaurice, Karen; Kelleher, Dermot; Rotger, Margalida; Fellay, Jacques; Martinez, Raquel; Pulit, Sara; Furrer, Hansjakob; Günthard, Huldrych F; Battegay, Manuel; Bernasconi, Enos; Schmid, Patrick; Hirschel, Bernard; Barnes, Eleanor; Klenerman, Paul; Telenti, Amalio; Rauch, Andri; Swiss HIV Cohort Study, (2011). Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance. Hepatology, 53(5), pp. 1446-54. Hoboken, N.J.: Wiley Interscience 10.1002/hep.24263
El Amari, E Boffi; Combescure, C; Yerly, S; Calmy, A; Kaiser, L; Hasse, B; Furrer, H; Cavassini, M; Vernazza, P; Hirsch, Hh; Bernasconi, E; Hirschel, B; Swiss HIV Cohort Study, (2011). Clinical relevance of cytomegalovirus viraemia(*,†). HIV medicine, 12(7), pp. 394-402. Oxford: Blackwell Science 10.1111/j.1468-1293.2010.00900.x
Ortiz, Millán; Poloni, Estella S; Furrer, Hansjakob; Kovari, Helen; Martinez, Raquel; Arnedo, Mireia; Elzi, Luigia; Bernasconi, Enos; Vernazza, Pietro; Hirschel, Bernard; Cavassini, Matthias; Ledergerber, Bruno; Günthard, Huldrych F; Telenti, Amalio; Tarr, Philip E; Swiss HIV Cohort Study, (2011). No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy. Journal of infectious diseases, 203(5), pp. 620-4. Cary, N.C.: Oxford University Press 10.1093/infdis/jiq106
Kaufmann, Gilbert R; Elzi, Luigia; Weber, Rainer; Furrer, Hansjakob; Giulieri, Stefano; Vernazza, Pietro; Bernasconi, Enos; Hirschel, Bernard; Battegay, Manuel; Swiss HIV Cohort Study, (2011). Interruptions of cART limits CD4 T-cell recovery and increases the risk for opportunistic complications and death. AIDS, 25(4), pp. 441-51. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/QAD.0b013e3283430013
Bucher, HC; Richter, W; Glass, TR; Magenta, L; Wang, Q; Cavassini, M; Vernazza, P; Hirschel, B; Weber, R; Furrer, H; Battegay, M; Bernasconi, E (2011). Small dense lipoproteins, apolipoprotein B and risk of coronary events in HIV-infected patients on antiretroviral therapy. Journal of acquired immune deficiency syndromes JAIDS, 60(2), pp. 135-142. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1097/QAI.0b013e31824476e1
Müller, Monika; Wandel, Simon; Colebunders, Robert; Attia, Suzanna; Furrer, Hansjakob; Egger, Matthias (2010). Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet infectious diseases, 10(4), pp. 251-261. London: Elsevier 10.1016/S1473-3099(10)70026-8
Rotger, Margalida; Gsponer, Thomas; Martinez, Raquel; Taffé, Patrick; Elzi, Luigia; Vernazza, Pietro; Cavassini, Matthias; Bernasconi, Enos; Hirschel, Bernard; Furrer, Hansjakob; Weber, Rainer; Ledergerber, Bruno; Egger, Matthias; Telenti, Amalio; Tarr, Philip E (2010). Impact of single nucleotide polymorphisms and of clinical risk factors on new-onset diabetes mellitus in HIV-infected individuals. Clinical infectious diseases, 51(9), pp. 1090-1098. Cary, N.C.: The University of Chicago Press 10.1086/656630
Feller, Martin; Huwiler, Karin; Schoepfer, Alain; Shang, Aijing; Furrer, Hansjakob; Egger, Matthias (2010). Long-term antibiotic treatment for Crohn's disease: systematic review and meta-analysis of placebo-controlled trials. Clinical infectious diseases, 50(4), pp. 473-480. Cary, N.C.: The University of Chicago Press 10.1086/649923
Rohrbach, Janine; Robinson, Nicola; Harcourt, Gillian; Hammond, Emma; Gaudieri, Silvana; Gorgievski, Meri; Telenti, Amalio; Keiser, Olivia; Günthard, Huldrych F; Hirschel, Bernhard; Hoffmann, Matthias; Bernasconi, Enos; Battegay, Manuel; Furrer, Hansjakob; Klenerman, Paul; Rauch, Andri (2010). Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy. Gut, 59(9), pp. 1252-1258. London: BMJ Publishing Group 10.1136/gut.2009.205971
Franceschi, S; Lise, M; Clifford, G M; Rickenbach, M; Levi, F; Maspoli, M; Bouchardy, C; Dehler, S; Jundt, G; Ess, S; Bordoni, A; Konzelmann, I; Frick, H; Dal Maso, L; Elzi, L; Furrer, H; Calmy, A; Cavassini, M; Ledergerber, B and Keiser, O (2010). Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. British journal of cancer, 103(3), pp. 416-422. Basingstoke: Nature Publishing Group 10.1038/sj.bjc.6605756
Garzoni, Christian; Adler, Sabine; Boller, Christoph; Furrer, HansJakob; Villiger, Peter M (2010). Possible role of anti-TNF monoclonal antibodies in the treatment of Mycobacterium marinum infection. Rheumatology, 49(10), pp. 1991-3. Oxford: Oxford University Press 10.1093/rheumatology/keq146
Thurnheer, Maria Christine; Weber, Rainer; Toutous-Trellu, Laurence; Cavassini, Matthias; Elzi, Luigia; Schmid, Patrick; Bernasconi, Enos; Christen, Anna B; Zwahlen, Marcel; Furrer, Hansjakob (2010). Occurrence, risk factors, diagnosis and treatment of syphilis in the prospective observational Swiss HIV Cohort Study. AIDS, 24(12), pp. 1907-1916. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/QAD.0b013e32833bfe21
Alizon, Samuel; von Wyl, Viktor; Stadler, Tanja; Kouyos, Roger D; Yerly, Sabine; Hirschel, Bernard; Böni, Jürg; Shah, Cyril; Klimkait, Thomas; Furrer, Hansjakob; Rauch, Andri; Vernazza, Pietro L; Bernasconi, Enos; Battegay, Manuel; Bürgisser, Philippe; Telenti, Amalio; Günthard, Huldrych F; Bonhoeffer, Sebastian; Swiss HIV Cohort Study, (2010). Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load. PLoS pathogens, 6(9), e1001123. San Francisco, Calif.: Public Library of Science 10.1371/journal.ppat.1001123
Gran, Jon Michael; Røysland, Kjetil; Wolbers, Marcel; Didelez, Vanessa; Sterne, Jonathan A C; Ledergerber, Bruno; Furrer, Hansjakob; von Wyl, Viktor; Aalen, Odd O (2010). A sequential Cox approach for estimating the causal effect of treatment in the presence of time-dependent confounding applied to data from the Swiss HIV Cohort Study. Statistics in medicine, 29(26), pp. 2757-68. Hoboken, N.J.: Wiley-Blackwell 10.1002/sim.4048
Opportunistic Infections Project Team of the, Collaboration of Ob; Mocroft, Amanda; Reiss, Peter; Kirk, Ole; Mussini, Cristina; Girardi, Enrico; Morlat, Philippe; Stephan, Christoph; De Wit, Stephane; Doerholt, Katja; Ghosn, Jade; Bucher, Heiner C; Lundgren, Jens D; Chene, Genevieve; Miro, Jose M; Furrer, Hansjakob (2010). Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL? Clinical infectious diseases, 51(5), pp. 611-9. Cary, N.C.: Oxford University Press 10.1086/655761
Marzolini, Catia; Elzi, Luigia; Gibbons, Sara; Weber, Rainer; Fux, Christoph; Furrer, Hansjakob; Chave, Jean-Philippe; Cavassini, Matthias; Bernasconi, Enos; Calmy, Alexandra; Vernazza, Pietro; Khoo, Saye; Ledergerber, Bruno; Back, David; Battegay, Manuel; Swiss HIV Cohort Study, (2010). Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study. Antiviral therapy, 15(3), pp. 413-23. London: International Medical Press 10.3851/IMP1540
Kouyos, Roger D; von Wyl, Viktor; Yerly, Sabine; Böni, Jürg; Taffé, Patrick; Shah, Cyril; Bürgisser, Philippe; Klimkait, Thomas; Weber, Rainer; Hirschel, Bernard; Cavassini, Matthias; Furrer, Hansjakob; Battegay, Manuel; Vernazza, Pietro L; Bernasconi, Enos; Rickenbach, Martin; Ledergerber, Bruno; Bonhoeffer, Sebastian; Günthard, Huldrych F (2010). Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland. Journal of infectious diseases, 201(10), pp. 1488-97. Cary, N.C.: The University of Chicago Press 10.1086/651951
Mossdorf, Erik; Stoeckle, Marcel; Vincenz, Anja; Mwaigomole, Emmanuel Geofrey; Chiweka, Evarist; Kibatala, Patience; Urassa, Honoraty; Abdulla, Salim; Elzi, Luigia; Tanner, Marcel; Furrer, Hansjakob; Hatz, Christoph; Battegay, Manuel (2010). Impact of a national HIV voluntary counselling and testing (VCT) campaign on VCT in a rural hospital in Tanzania. Tropical medicine and international health TM&IH, 15(5), pp. 567-73. Oxford: Blackwell Science 10.1111/j.1365-3156.2010.02490.x
Lubomirov, Rubin; di Iulio, Julia; Fayet, Aurélie; Colombo, Sara; Martinez, Raquel; Marzolini, Catia; Furrer, Hansjakob; Vernazza, Pietro; Calmy, Alexandra; Cavassini, Matthias; Ledergerber, Bruno; Rentsch, Katharina; Descombes, Patrick; Buclin, Thierry; Decosterd, Laurent A; Csajka, Chantal; Telenti, Amalio; Swiss HIV Cohort Study, (2010). ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir. Pharmacogenetics and genomics, 20(4), pp. 217-30. London: Lippincott Williams & Wilkins 10.1097/FPC.0b013e328336eee4
Elzi, Luigia; Marzolini, Catia; Furrer, Hansjakob; Ledergerber, Bruno; Cavassini, Matthias; Hirschel, Bernard; Vernazza, Pietro; Bernasconi, Enos; Weber, Rainer; Battegay, Manuel; Swiss HIV Cohort Study, (2010). Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008. Archives of internal medicine, 170(1), pp. 57-65. Chicago, Ill.: American Medical Association 10.1001/archinternmed.2009.432
Rauch, Andri; Kutalik, Zoltán; Descombes, Patrick; Cai, Tao; Di Iulio, Julia; Mueller, Tobias; Bochud, Murielle; Battegay, Manuel; Bernasconi, Enos; Borovicka, Jan; Colombo, Sara; Cerny, Andreas; Dufour, Jean-François; Furrer, Hansjakob; Günthard, Huldrych F; Heim, Markus; Hirschel, Bernard; Malinverni, Raffaele; Moradpour, Darius; Müllhaupt, Beat; ... (2010). Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology, 138(4), 1338-45, 1345.e1-7. Philadelphia, Pa.: Elsevier 10.1053/j.gastro.2009.12.056
Glass, Tracy R; Battegay, Manuel; Cavassini, Matthias; De Geest, Sabina; Furrer, Hansjakob; Vernazza, Pietro L; Hirschel, Bernard; Bernasconi, Enos; Rickenbach, Martin; Günthard, Huldrych F; Bucher, Heiner C; Swiss HIV Cohort Study, (2010). Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes JAIDS, 54(2), pp. 197-203. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1097/QAI.0b013e3181ca48bf
Scherrer, Alexandra U; von Wyl, Viktor; Fux, Christof A; Opravil, Milos; Bucher, Heiner C; Fayet, Aurélie; Decosterd, Laurent A; Hirschel, Bernhard; Khanlari, Bettina; Yerly, Sabine; Klimkait, Thomas; Furrer, Hansjakob; Ledergerber, Bruno; Günthard, Huldrych F; Swiss HIV Cohort Study, (2010). Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failures. Journal of acquired immune deficiency syndromes JAIDS, 53(4), pp. 464-71. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1097/QAI.0b013e3181bca4ec
Mocroft, Amanda; Sterne, Jonathan A C; Egger, Matthias; May, Margaret; Grabar, Sophie; Furrer, Hansjakob; Sabin, Caroline; Fatkenheuer, Gerd; Justice, Amy; Reiss, Peter; d'Arminio Monforte, Antonella; Gill, John; Hogg, Robert; Bonnet, Fabrice; Kitahata, Mari; Staszewski, Schlomo; Casabona, Jordi; Harris, Ross; Saag, Michael (2009). Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. Clinical infectious diseases, 48(8), pp. 1138-51. Cary, N.C.: Oxford University Press 10.1086/597468
Evison, John; Farese, Stefan; Seitz, Michael; Uehlinger, Dominik E; Furrer, Hansjakob; Mühlemann, Kathrin (2009). Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients. Clinical infectious diseases, 48(10), pp. 1402-12. Cary, N.C.: The University of Chicago Press 10.1086/598193
Rotger, Margalida; Bayard, Cornelia; Taffé, Patrick; Martinez, Raquel; Cavassini, Matthias; Bernasconi, Enos; Battegay, Manuel; Hirschel, Bernard; Furrer, Hansjakob; Witteck, Andrea; Weber, Rainer; Ledergerber, Bruno; Telenti, Amalio; Tarr, Philip E (2009). Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study. Circulation - cardiovascular genetics, 2(6), pp. 621-8. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1161/CIRCGENETICS.109.874412
Ballif, Marie; Ledergerber, Bruno; Battegay, Manuel; Cavassini, Matthias; Bernasconi, Enos; Schmid, Patrick; Hirschel, Bernard; Furrer, Hansjakob; Rickenbach, Martin; Opravil, Milos; Weber, Rainer (2009). Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007. PLoS ONE, 4(12), e8275. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0008275
Tschochner, Monika; Chopra, Abha; Maiden, Tanya M; Ahmad, Imran F; James, Ian; Furrer, Hansjakob; Günthard, Huldrych F; Mallal, Simon; Rauch, Andri; John, Mina (2009). Effects of HIV type-1 immune selection on susceptability to integrase inhibitor resistance. Antiviral therapy, 14(7), pp. 953-64. London: International Medical Press 10.3851/IMP1419
Podlekareva, Daria N; Mocroft, Amanda; Post, Frank A; Riekstina, Vija; Miro, Jose M; Furrer, Hansjakob; Bruyand, Mathias; Panteleev, Alexander M; Rakhmanova, Aza G; Girardi, Enrico; Losso, Marcello H; Toibaro, Javier J; Caylá, Joan; Miller, Rob F; Obel, Niels; Skrahina, Alena; Chentsova, Nelly; Lundgren, Jens D; Kirk, Ole (2009). Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina. AIDS, 23(18), pp. 2485-95. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/QAD.0b013e3283326879
Lanoy, Emilie; May, Margaret; Mocroft, Amanda; Phillip, Andrew; Justice, Amy; Chêne, Geneviève; Furrer, Hansjakob; Sterling, Timothy; Monforte, Antonella D'Arminio; Force, Lluís; Gill, John; Harris, Ross; Hogg, Robert S; Rockstroh, Jürgen; Saag, Mike; Khaykin, Pavel; de Wolf, Frank; Sterne, Jonathan A C; Costagliola, Dominique (2009). Prognosis of patients treated with cART from 36 months after initiation, according to current and previous CD4 cell count and plasma HIV-1 RNA measurements. AIDS, 23(16), pp. 2199-208. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/QAD.0b013e3283305a00
Rauch, Andri; James, Ian; Pfafferott, Katja; Nolan, David; Klenerman, Paul; Cheng, Wendy; Mollison, Lindsay; McCaughan, Geoff; Shackel, Nick; Jeffrey, Gary P; Baker, Ross; Freitas, Elizabeth; Humphreys, Isla; Furrer, Hansjakob; Günthard, Huldrych F; Hirschel, Bernard; Mallal, Simon; John, Mina; Lucas, Michaela; Barnes, Eleanor; ... (2009). Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressure. Hepatology, 50(4), pp. 1017-29. Hoboken, N.J.: Wiley Interscience 10.1002/hep.23101
Weber, R; Huber, M; Rickenbach, M; Furrer, H; Elzi, L; Hirschel, B; Cavassini, M; Bernasconi, E; Schmid, P; Ledergerber, B (2009). Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study. HIV medicine, 10(7), pp. 407-16. Oxford: Blackwell Science 10.1111/j.1468-1293.2009.00701.x
Conen, Anna; Fehr, Jan; Glass, Tracy R; Furrer, Hansjakob; Weber, Rainer; Vernazza, Pietro; Hirschel, Bernard; Cavassini, Matthias; Bernasconi, Enos; Bucher, Heiner C; Battegay, Manuel (2009). Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study. Antiviral therapy, 14(3), pp. 349-57. London: International Medical Press
Combescure, Christophe; Vallier, N; Ledergerber, B; Cavassini, M; Furrer, H; Rauch, A; Battegay, M; Bernasconi, E; Vernazza, P; Hirschel, B (2009). How reliable is an undetectable viral load? HIV medicine, 10(8), pp. 470-6. Oxford: Blackwell Science 10.1111/j.1468-1293.2009.00714.x
Gaudieri, Silvana; Rauch, Andri; Pfafferott, Katja; Barnes, Eleanor; Cheng, Wendy; McCaughan, Geoff; Shackel, Nick; Jeffrey, Gary P; Mollison, Lindsay; Baker, Ross; Furrer, Hansjakob; Günthard, Huldrych F; Freitas, Elizabeth; Humphreys, Isla; Klenerman, Paul; Mallal, Simon; James, Ian; Roberts, Stuart; Nolan, David and Lucas, Michaela (2009). Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy. Hepatology, 49(4), pp. 1069-82. Hoboken, N.J.: Wiley Interscience 10.1002/hep.22773
di Iulio, Julia; Fayet, Aurélie; Arab-Alameddine, Mona; Rotger, Margalida; Lubomirov, Rubin; Cavassini, Matthias; Furrer, Hansjakob; Günthard, Huldrych F; Colombo, Sara; Csajka, Chantal; Eap, Chin B; Decosterd, Laurent A; Telenti, Amalio (2009). In vivo analysis of efavirenz metabolism in individuals with impaired CYP2A6 function. Pharmacogenetics and genomics, 19(4), pp. 300-9. London: Lippincott Williams & Wilkins 10.1097/FPC.0b013e328328d577
von Wyl, Viktor; Yerly, Sabine; Bürgisser, Philippe; Klimkait, Thomas; Battegay, Manuel; Bernasconi, Enos; Cavassini, Matthias; Furrer, Hansjakob; Hirschel, Bernard; Vernazza, Pietro L; Francioli, Patrick; Bonhoeffer, Sebastian; Ledergerber, Bruno; Günthard Huldrych, F; Swiss HIV Cohort, Study (2009). Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland. Clinical infectious diseases, 48(7), pp. 979-87. Cary, N.C.: The University of Chicago Press 10.1086/597352
Veit, Olivia; Niedrig, Matthias; Chapuis-Taillard, Caroline; Cavassini, Matthias; Mossdorf, Erik; Schmid, Patrick; Bae, Hi-Gung; Litzba, Nadine; Staub, Thomas; Hatz, Christoph; Furrer, Hansjakob (2009). Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients. Clinical infectious diseases, 48(5), pp. 659-66. Cary, N.C.: The University of Chicago Press 10.1086/597006
Gayet-Ageron, A; Ninet, B; Toutous-Trellu, L; Lautenschlager, S; Furrer, H; Piguet, V; Schrenzel, J; Hirschel, B (2009). Assessment of a real-time PCR test to diagnose syphilis from diverse biological samples. Sexually transmitted diseases, 85(4), pp. 264-9. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1136/sti.2008.034314
Young, Jim; Glass, Tracy R; Bernasconi, Enos; Rickenbach, Martin; Furrer, Hansjakob; Hirschel, Bernard; Tarr, Philip E; Vernazza, Pietro; Battegay, Manuel; Bucher, Heiner C (2009). Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy. Journal of clinical epidemiology, 62(6), pp. 632-41. New York, N.Y.: Elsevier 10.1016/j.jclinepi.2008.07.015
Keiser, Olivia; Orrell, Catherine; Egger, Matthias; Wood, Robin; Brinkhof, Martin W G; Furrer, Hansjakob; van Cutsem, Gilles; Ledergerber, Bruno; Boulle, Andrew (2008). Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared. PLoS medicine, 5(7), e148. San Francisco, Calif.: Public Library of Science 10.1371/journal.pmed.0050148
Vo, Thi Tuyet Nhung; Ledergerber, Bruno; Keiser, Olivia; Hirschel, Bernard; Furrer, Hansjakob; Battegay, Manuel; Cavassini, Matthias; Bernasconi, Enos; Vernazza, Pietro; Weber, Rainer (2008). Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort Study. Journal of infectious diseases, 197(12), pp. 1685-94. Cary, N.C.: The University of Chicago Press 10.1086/588141
Wunder, D M; Fux, C A; Bersinger, N A; Mueller, N J; Hirschel, B; Cavassini, M; Elzi, L; Schmid, P; Bernasconi, E; Mueller, B; Furrer, H (2008). Androgen and gonadotropin patterns differ in HIV-1-infected men who develop lipoatrophy during antiretroviral therapy: a case-control study. HIV medicine, 9(6), pp. 427-32. Oxford: Blackwell Science 10.1111/j.1468-1293.2008.00578.x
Fux, Christoph A; Rauch, Andri; Simcock, Mathew; Bucher, Heiner C; Hirschel, Bernard; Opravil, Milos; Vernazza, Pietro; Cavassini, Matthias; Bernasconi, Enos; Elzi, Luigia; Furrer, Hansjakob (2008). Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study. Antiviral therapy, 13(8), pp. 1077-82. London: International Medical Press
Rauch, Andri; Nolan, David; Thurnheer, Christine; Fux, Christoph A; Cavassini, Matthias; Chave, Jean-Philippe; Opravil, Milos; Phillips, Elizabeth; Mallal, Simon; Furrer, Hansjakob (2008). Refining abacavir hypersensitivity diagnoses using a structured clinical assessment and genetic testing in the Swiss HIV Cohort Study. Antiviral therapy, 13(8), pp. 1019-28. London: International Medical Press
Khanna, Nina; Opravil, Milos; Furrer, Hansjakob; Cavassini, Matthias; Vernazza, Pietro; Bernasconi, Enos; Weber, Rainer; Hirschel, Bernard; Battegay, Manuel; Kaufmann, Gilbert R (2008). CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. Clinical infectious diseases, 47(8), pp. 1093-101. Cary, N.C.: The University of Chicago Press 10.1086/592113
Colombo, Sara; Rauch, Andri; Rotger, Margalida; Fellay, Jacques; Martinez, Raquel; Fux, Christoph; Thurnheer, Christine; Günthard, Huldrych F; Goldstein, David B; Furrer, Hansjakob; Telenti, Amalio (2008). The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir. Journal of infectious diseases, 198(6), pp. 864-7. Cary, N.C.: The University of Chicago Press 10.1086/591184
Rauch, Andri; Gaudieri, Silvana; Evison, John; Nolan, David; Cavassini, Matthias; Weber, Rainer; James, Ian; Furrer, Hansjakob (2008). Low current and nadir CD4+ T-cell counts are associated with higher hepatitis C virus RNA levels in the Swiss HIV cohort study. Antiviral therapy, 13(3), pp. 455-60. London: International Medical Press
Rauch, Andri; Nolan, David; Furrer, Hansjakob; McKinnon, Elizabeth; John, Mina; Mallal, Simon; Gaudieri, Silvana; Günthard, Huldrych F; Schmid, Patrick; Battegay, Manuel; Hirschel, Bernard; Telenti, Amalio; James, Ian (2008). HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy. Clinical infectious diseases, 46(12), pp. 1921-5. Cary, N.C.: The University of Chicago Press 10.1086/588479
von Wyl, Viktor; Yerly, Sabine; Böni, Jürg; Bürgisser, Philippe; Klimkait, Thomas; Battegay, Manuel; Bernasconi, Enos; Cavassini, Matthias; Furrer, Hansjakob; Hirschel, Bernard; Vernazza, Pietro L; Rickenbach, Martin; Ledergerber, Bruno; Günthard, Huldrych F (2008). Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir. Clinical infectious diseases, 46(8), pp. 1299-309. Cary, N.C.: The University of Chicago Press 10.1086/528863
Wolbers, M; Bucher, H C; Furrer, H; Rickenbach, M; Cavassini, M; Weber, R; Schmid, P; Bernasconi, E; Hirschel, B; Battegay, M (2008). Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV medicine, 9(6), pp. 397-405. Oxford: Blackwell Science 10.1111/j.1468-1293.2008.00566.x
Glass, Tracy R; De Geest, Sabina; Hirschel, Bernard; Battegay, Manuel; Furrer, Hansjakob; Covassini, Matthias; Vernazza, Pietro L; Bernasconi, Enos; Rickenboch, Martin; Weber, Rainer; Bucher, Heiner C (2008). Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients. Antiviral therapy, 13(1), pp. 77-85. London: International Medical Press
El Amari, Emmanuelle Boffi; Toutous-Trellu, Laurence; Gayet-Ageron, Angèle; Baumann, Michele; Cathomas, Gieri; Steffen, Ingrid; Erb, Peter; Mueller, Nicolas J; Furrer, Hansjakob; Cavassini, Matthias; Vernazza, Pietro; Hirsch, Hans H; Bernasconi, Enos; Hirschel, Bernard (2008). Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era. AIDS, 22(9), pp. 1019-28. Hagerstown, Md.: Lippincott Williams & Wilkins
Berger, Simona; Schad, Tanja; von Wyl, Viktor; Ehlert, Ulrike; Zellweger, Claudine; Furrer, Hansjakob; Regli, Daniel; Vernazza, Pietro; Ledergerber, Bruno; Battegay, Manuel; Weber, Rainer; Gaab, Jens (2008). Effects of cognitive behavioral stress management on HIV-1 RNA, CD4 cell counts and psychosocial parameters of HIV-infected persons. AIDS, 22(6), pp. 767-75. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/QAD.0b013e3282f511dc
Polesel, Jerry; Clifford, Gary M; Rickenbach, Martin; Dal Maso, Luigino; Battegay, Manuel; Bouchardy, Christine; Furrer, Hansjakob; Hasse, Barbara; Levi, Fabio; Probst-Hensch, Nicole M; Schmid, Patrick; Franceschi, Silvia (2008). Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy. AIDS, 22(2), pp. 301-6. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/QAD.0b013e3282f2705d
Keiser, Olivia; Orrell, Catherine; Egger, Matthias; Wood, Robin; Brinkhof, Martin; Furrer, Hansjakob; van Cutsem, Gilles; Ledergerber, Bruno; Boulle, Andrew (2008). Correction: Public-Health and Individual Approaches to Antiretroviral Therapy: Township South Africa and Switzerland Compared. PLoS medicine, 5(9), e195. Public Library of Science 10.1371/journal.pmed.0050195
Elzi, L; Schlegel, M; Weber, R; Hirschel, B; Cavassini, M; Schmid, P; Bernasconi, E; Rickenbach, M; Furrer, H; Swiss, HIV Cohort Study (2007). Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission. Clinical infectious diseases, 44(1), pp. 94-102. Cary, N.C.: The University of Chicago Press 10.1086/510080
Feller, Martin; Huwiler, Karin; Stephan, Roger; Altpeter, Ekkehardt; Shang, Aijing; Furrer, Hansjakob; Pfyffer, Gaby E; Jemmi, Thomas; Baumgartner, Andreas; Egger, Matthias (2007). Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet infectious diseases, 7(9), pp. 607-613. London: Elsevier 10.1016/S1473-3099(07)70211-6
Sterne, JA; May, M; Bucher, HC; Ledergerber, B; Furrer, H; Cavassini, M; Bernasconi, E; Hirschel, B; Egger, M; Swiss, HIV Cohort (2007). HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapy. Journal of internal medicine, 261(3), pp. 255-67. Oxford: Blackwell Scientific Publications 10.1111/j.1365-2796.2006.01761.x
Ledergerber, B; Furrer, H; Rickenbach, M; Lehmann, R; Elzi, L; Hirschel, B; Cavassini, M; Bernasconi, E; Schmid, P; Egger, M; Weber, R; Swiss, HIV Cohort Study (2007). Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study. Clinical infectious diseases, 45(1), pp. 111-9. Cary, N.C.: The University of Chicago Press 10.1086/518619
Keiser, Olivia; Fellay, Jacques; Opravil, Milos; Hirsch, Hans H; Hirschel, Bernard; Bernasconi, Enos; Vernazza, Pietro L; Rickenbach, Martin; Telenti, Amalio; Furrer, Hansjakob (2007). Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification. Antiviral therapy, 12(8), pp. 1157-64. London: International Medical Press
Fux, Christoph A; Christen, Anna; Zgraggen, Susanne; Mohaupt, Markus G; Furrer, Hansjakob (2007). Effect of tenofovir on renal glomerular and tubular function. AIDS, 21(11), pp. 1483-5. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/QAD.0b013e328216f15b
Bergmann-Hug, K; Furrer, H; Helbling, A (2007). Attagenus pellio: a potential cause of indoor allergy. Journal of investigational allergology & clinical immunology, -17(3), pp. 203-4. Barcelona: Esmon Publicidad
Fux, CA; Simcock, M; Wolbers, M; Bucher, HC; Hirschel, B; Opravil, M; Vernazza, P; Cavassini, M; Bernasconi, E; Elzi, L; Furrer, H; Swiss, HIV Cohort Study (2007). Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study. Antiviral therapy, 12(8), pp. 1165-73. London: International Medical Press
Wolbers, M; Opravil, M; von Wyl, V; Hirschel, B; Furrer, H; Cavassini, M; Vernazza, P; Bernasconi, E; Battegay, M; Yerly, S; Günthard, H; Bucher, HC; Swiss, HIV Cohort Study (2007). Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study. AIDS, 21(16), pp. 2201-7. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/QAD.0b013e3282efacb1
Simcock, M; Blasko, M; Karrer, U; Bertisch, B; Pless, M; Blumer, L; Vora, S; Robinson, JO; Bernasconi, E; Terziroli, B; Moirandat-Rytz, S; Furrer, H; Hirschel, B; Vernazza, P; Sendi, P; Rickenbach, M; Bucher, HC; Battegay, M; Koller, MT and Swiss, HIV Cohort Study (2007). Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study. Antiviral therapy, 12(6), pp. 931-9. London: International Medical Press
Wolbers, M; Battegay, M; Hirschel, B; Furrer, H; Cavassini, M; Hasse, B; Vernazza, PL; Bernasconi, E; Kaufmann, G; Bucher, HC; Swiss, HIV Cohort Study (2007). CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy. Antiviral therapy, 12(6), pp. 889-97. London: International Medical Press
Battegay, Manuel; Fluckiger, Ursula; Hirschel, Bernard; Furrer, Hansjakob (2007). Late presentation of HIV-infected individuals. Antiviral therapy, 12(6), pp. 841-51. London: International Medical Press
von Wyl, V; Yerly, S; Böni, J; Bürgisser, P; Klimkait, T; Battegay, M; Furrer, H; Telenti, A; Hirschel, B; Vernazza, PL; Bernasconi, E; Rickenbach, M; Perrin, L; Ledergerber, B; Günthard, HF; for, the Swiss HIV Cohort Study (2007). Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. Archives of internal medicine, 167(16), pp. 1782-90. Chicago, Ill.: American Medical Association 10.1001/archinte.167.16.1782
Arnedo, M; Taffé, P; Sahli, R; Furrer, H; Hirschel, B; Elzi, L; Weber, R; Vernazza, P; Bernasconi, E; Darioli, R; Bergmann, S; Beckmann, JS; Telenti, A; Tarr, PE; Swiss, HIV Cohort Study (2007). Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy. Pharmacogenetics and genomics, 17(9), pp. 755-64. London: Lippincott Williams & Wilkins 10.1097/FPC.0b013e32814db8b7
Glass, TR; Weber, R; Vernazza, PL; Rickenbach, M; Furrer, H; Bernasconi, E; Cavassini, M; Hirschel, B; Battegay, M; Bucher, HC; Swiss, HIV Cohort Study (2007). Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study. HIV clinical trials, 8(2), pp. 77-85. St. Louis, Mo.: Thomas Land Publishers 10.1310/hct0802-77
Rotger, Margalida; Colombo, Sara; Furrer, Hansjakob; Décosterd, Laurent; Buclin, Thierry; Telenti, Amalio (2007). Does tenofovir influence efavirenz pharmacokinetics? Antiviral therapy, 12(1), pp. 115-8. London: International Medical Press
Wunder, DM; Bersinger, NA; Fux, CA; Mueller, NJ; Hirschel, B; Cavassini, M; Elzi, L; Schmid, P; Bernasconi, E; Mueller, B; Furrer, H; HIV Cohort Study, Swiss (2007). Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy. Antiviral therapy, 12(2), pp. 261-5. London: International Medical Press
Rauch, A; Laird, R; McKinnon, E; Telenti, A; Furrer, H; Weber, R; Smillie, D; Gaudieri, S; the, Swiss HIV Cohort Study (2007). Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection. Tissue antigens, 69 Suppl 1, pp. 237-240. Oxford: Wiley-Blackwell 10.1111/j.1399-0039.2006.773_4.x
Hoffmann, Matthias; Reichmuth, Markus; Fantelli, Karin; Schoch, Otto D; Fierz, Walter; Furrer, Hansjörg; Vernazza, Pietro (2007). Conventional tuberculin skin testing versus T-cell-based assays in the diagnosis of latent tuberculosis infection in HIV-positive patients. AIDS, 21(3), pp. 390-2. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/QAD.0b013e328012164b
Rotger, M; Tegude, H; Colombo, S; Cavassini, M; Furrer, H; Décosterd, L; Blievernicht, J; Saussele, T; Günthard, H F; Schwab, M; Eichelbaum, M; Telenti, A; Zanger, U M (2007). Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individuals. Clinical pharmacology & therapeutics, 81(4), pp. 557-66. New York, N.Y.: Nature Publishing Group 10.1038/sj.clpt.6100072
Elzi, Luigia; Furrer, Hansjakob (2007). Reply to Hamlyn et al. Clinical infectious diseases, 44(10), pp. 1394-1395. The University of Chicago Press 10.1086/516607
Müller, NJ; Furrer, H; Kaiser, L; Hirschel, B; Cavassini, M; Fellay, J; Chave, JP; Wüthrich, RP; Weber, M; Müllhaupt, B; Candinas, D; Reichen, J; Giostra, E; Mentha, G; Halkic, N; Hirsch, HH; Weber, R; Swiss, HIV Cohort Study (2006). HIV and solid organ transplantation: the Swiss experience. Swiss medical weekly, 136(11-12), pp. 194-6. Muttenz: EMH Schweizerischer Ärzteverlag
Genton, Blaise; D'Acremont, Valérie; Furrer, Hans-Jacob; Hatz, Christoph; Loutan, Louis (2006). Hepatitis A vaccines and the elderly. Travel medicine and infectious disease, 4(6), pp. 303-312. Amsterdam: Elsevier
Gaudieri, Silvana; Rauch, Andri; Park, Lawrence P; Freitas, Elizabeth; Herrmann, Susan; Jeffrey, Gary; Cheng, Wendy; Pfafferott, Katja; Naidoo, Kiloshni; Chapman, Russell; Battegay, Manuel; Weber, Rainer; Telenti, Amalio; Furrer, Hansjakob; James, Ian; Lucas, Michaela; Mallal, Simon A (2006). Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection. Journal of virology, 80(22), pp. 11094-104. Baltimore: American Society for Microbiology 10.1128/JVI.00912-06
Colombo, S; Buclin, T; Décosterd, LA; Telenti, A; Furrer, H; Lee, BL; Biollaz, J; Eap, CB; Swiss, HIV Cohort Study (2006). Orosomucoid (alpha1-acid glycoprotein) plasma concentration and genetic variants: effects on human immunodeficiency virus protease inhibitor clearance and cellular accumulation. Clinical pharmacology & therapeutics, 80(4), pp. 307-18. New York, N.Y.: Nature Publishing Group 10.1016/j.clpt.2006.06.006
Glass, TR; Ungsedhapand, C; Wolbers, M; Weber, R; Vernazza, PL; Rickenbach, M; Furrer, H; Bernasconi, E; Cavassini, M; Hirschel, B; Battegay, M; Bucher, HC; Swiss, HIV Cohort Study (2006). Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study. HIV medicine, 7(6), pp. 404-10. Oxford: Blackwell Science 10.1111/j.1468-1293.2006.00400.x
Ananworanich, J; Gayet-Ageron, A; Le Braz, M; Prasithsirikul, W; Chetchotisakd, P; Kiertiburanakul, S; Munsakul, W; Raksakulkarn, P; Tansuphasawasdikul, S; Sirivichayakul, S; Cavassini, M; Karrer, U; Genné, D; Nüesch, R; Vernazza, P; Bernasconi, E; Leduc, D; Satchell, C; Yerly, S; Perrin, L; ... (2006). CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial. Lancet, 368(9534), pp. 459-65. London: Elsevier 10.1016/S0140-6736(06)69153-8
Briel, M; Bucher, H C; Boscacci, R; Furrer, H (2006). Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection. Cochrane database of systematic reviews, 3(3), CD006150. Chichester: WileyInterscience 10.1002/14651858.CD006150
Boscacci, Rémy T; Buclin, Thierry; Furrer, Hansjakob; Fux, Christoph A (2006). A case of voluntary intoxication with efavirenz and lamivudine. AIDS, 20(9), pp. 1352-4. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/01.aids.0000232256.97027.c9
Buehlmann, Manuela; Chave, Jean-Philippe; Flepp, Markus; Schiffer, Veronique; Keiser, Olivia; Furrer, Hansjakob (2006). Tenofovir-containing nucleoside/nucleotide-only antiretroviral maintenance therapy: decision making and virological outcome. HIV clinical trials, 7(2), pp. 48-54. St. Louis, Mo.: Thomas Land Publishers 10.1310/D0WD-ARAU-U1EF-30MM
Colombo, S; Telenti, A; Buclin, T; Furrer, H; Lee, BL; Biollaz, J; Decosterd, LA; Swiss, HIV Cohort Study (2006). Are plasma levels valid surrogates for cellular concentrations of antiretroviral drugs in HIV-infected patients? Therapeutic drug monitoring, 28(3), pp. 332-8. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/01.ftd.0000211807.74192.62
Bertschy, S; Opravil, M; Cavassini, M; Bernasconi, E; Schiffer, V; Schmid, P; Flepp, M; Chave, JP; Christen, A; Furrer, H; Swiss, HIV Cohort Study (2006). Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy. Clinical microbiology and infection, 12(7), pp. 666-71. Oxford: Blackwell Publishing 10.1111/j.1469-0691.2006.01459.x
Zinkernagel, AS; von Wyl, V; Ledergerber, B; Rickenbach, M; Furrer, H; Battegay, M; Hirschel, B; Tarr, PE; Opravil, M; Bernasconi, E; Schmid, P; Weber, R; Swiss, HIV Cohort Study (2006). Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study. Antiviral therapy, 11(2), pp. 131-42. London: International Medical Press
Müller, V; Ledergerber, B; Perrin, L; Klimkait, T; Furrer, H; Telenti, A; Bernasconi, E; Vernazza, P; Günthard, HF; Bonhoeffer, S; Swiss, HIV Cohort Study (2006). Stable virulence levels in the HIV epidemic of Switzerland over two decades. AIDS, 20(6), pp. 889-94. Hagerstown, Md.: Lippincott Williams & Wilkins
Glass, Tracy R; De Geest, Sabina; Weber, Rainer; Vernazza, Pietro L; Rickenbach, Martin; Furrer, Hansjakob; Bernasconi, Enos; Cavassini, Matthias; Hirschel, Bernard; Battegay, Manuel; Bucher, Heiner C (2006). Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes JAIDS, 41(3), pp. 385-92. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1097/01.qai.0000186371.95301.52
Rossi, M; Zimmerli, W; Furrer, H; Zanetti, G; Mühlemann, K; Täuber, MG; Schweizerische, Gesellschaft für Infektiologie (2005). [Antibiotic prophylaxis for late blood-borne infections of joint prostheses]. Schweizerische Monatsschrift für Zahnmedizin, 115(6), pp. 571-9. Bern: Schweizerische Zahnärzte-Gesellschaft
Briel, M; Boscacci, R; Furrer, H; Bucher, HC (2005). Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection: a meta-analysis of randomised controlled trials. BMC infectious diseases, 5(5), p. 101. London: BioMed Central 10.1186/1471-2334-5-101
Karrer, U; Ledergerber, B; Furrer, H; Elzi, L; Battegay, M; Cavassini, M; Gayet-Ageron, A; Hirschel, B; Schmid, P; Russotti, M; Weber, R; Speck, RF; Swiss, HIV Cohort Study (2005). Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir. AIDS, 19(17), pp. 1987-94. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/01.aids.0000194136.73876.9c
Schüpbach, J; Günthard, H; Joos, B; Fischer, M; Böni, J; Tomasik, Z; Yerly, S; Perrin, L; Battegay, M; Furrer, H; Vernazza, P; Bernasconi, E; Hirschel, B; Swiss, HIV Cohort Study (2005). HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss. Journal of acquired immune deficiency syndromes JAIDS, 40(3), pp. 250-6. Philadelphia, Pa.: Lippincott Williams & Wilkins
Wunder, D; Bersinger, NA; Fux, C; Weber, R; Bernasconi, E; Cavassini, M; Bucher, HC; Schiffer, V; Schmid, P; Furrer, H; Swiss, HIV Cohort Study (2005). Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapy. AIDS, 19(16), pp. 1837-42. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/01.aids.0000189852.21441.2a
Rotger, M; Taffe, P; Bleiber, G; Gunthard, HF; Furrer, H; Vernazza, P; Drechsler, H; Bernasconi, E; Rickenbach, M; Telenti, A; Swiss, HIV Cohort Study (2005). Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia. Journal of infectious diseases, 192(8), pp. 1381-6. Cary, N.C.: The University of Chicago Press 10.1086/466531
Young, J; Weber, R; Rickenbach, M; Furrer, H; Bernasconi, E; Hirschel, B; Tarr, PE; Vernazza, P; Battegay, M; Bucher, HC (2005). Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study. Antiviral therapy, 10(5), pp. 585-91. London: International Medical Press
Colombo, S; Soranzo, N; Rotger, M; Sprenger, R; Bleiber, G; Furrer, H; Buclin, T; Goldstein, D; Décosterd, L; Telenti, A; Swiss, HIV Cohort Study (2005). Influence of ABCB1, ABCC1, ABCC2, and ABCG2 haplotypes on the cellular exposure of nelfinavir in vivo. Pharmacogenetics and genomics, 15(9), pp. 599-608. London: Lippincott Williams & Wilkins 10.1097/01.fpc.0000172241.42546.d3
Rauch, A; Rickenbach, M; Weber, R; Hirschel, B; Tarr, PE; Bucher, HC; Vernazza, P; Bernasconi, E; Zinkernagel, AS; Evison, J; Furrer, H; Swiss, HIV Cohort Study (2005). Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study. Clinical infectious diseases, 41(3), pp. 395-402. Cary, N.C.: The University of Chicago Press 10.1086/431486
Kaufmann, GR; Furrer, H; Ledergerber, B; Perrin, L; Opravil, M; Vernazza, P; Cavassini, M; Bernasconi, E; Rickenbach, M; Hirschel, B; Battegay, M; Swiss, HIV Cohort Study (2005). Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clinical infectious diseases, 41(3), pp. 361-72. Cary, N.C.: The University of Chicago Press 10.1086/431484
Cavassini, ML; D'Acremont, V; Furrer, H; Genton, B; Tarr, PE (2005). Pharmacotherapy, vaccines and malaria advice for HIV-infected travellers. Expert opinion on pharmacotherapy, 6(6), pp. 891-913. London: Informa Healthcare 10.1517/14656566.6.891
Rotger, M; Colombo, S; Furrer, H; Bleiber, G; Buclin, T; Lee, BL; Keiser, O; Biollaz, J; Décosterd, L; Telenti, A; Swiss, HIV Cohort Study (2005). Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients. Pharmacogenetics and genomics, 15(1), pp. 1-5. London: Lippincott Williams & Wilkins
Tarr, PE; Taffé, P; Bleiber, G; Furrer, H; Rotger, M; Martinez, R; Hirschel, B; Battegay, M; Weber, R; Vernazza, P; Bernasconi, E; Darioli, R; Rickenbach, M; Ledergerber, B; Telenti, A; Swiss, HIV Cohort Study (2005). Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders. Journal of infectious diseases, 191(9), pp. 1419-26. Cary, N.C.: The University of Chicago Press 10.1086/429295
Young, J; Rickenbach, M; Weber, R; Furrer, H; Bernasconi, E; Hirschel, B; Tarr, PE; Vernazza, P; Battegay, M; Bucher, HC (2005). Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study. Antiviral therapy, 10(1), pp. 73-81. London: International Medical Press
Rauch, A; Egger, M; Reichen, J; Furrer, H; Swiss, HIV Cohort Study (2005). Chronic hepatitis C in HIV-infected patients: low eligibility and applicability of therapy with pegylated interferon-alpha plus ribavirin. Journal of acquired immune deficiency syndromes JAIDS, 38(2), pp. 238-40. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1097/01.qai.0000148535.97081.72
Eigenmann, Christina; Flepp, Markus; Bernasconi, Enos; Schiffer, Veronique; Telenti, Amalio; Bucher, Heiner; Wagels, Thomas; Egger, Martin; Furrer, Hansjakob (2003). Low Incidence of Community-Acquired Pneumonia among Human Immunodeficiency Virus-Infected Patients after Interruption of Pneumocystis carinii Pneumonia Prophylaxis. Clinical infectious diseases, 36(7), pp. 917-921. The University of Chicago Press 10.1086/368190
Bissig, Karl-Dimiter; Zimmermann, Arthur; Bernasch, Dirke; Furrer, Hansjakob; Dufour, Jean-François (2003). Herpes simplex virus hepatitis 4 years after liver transplantation. Journal of gastroenterology, 38(10), pp. 1005-1008. Springer 10.1007/s00535-002-1186-0
Opravil, Milos; Hirschel, Bernard; Lazzarin, Adriano; Furrer, Hansjakob; Chave, Jean-Philippe; Yerly, Sabine; Bisset, Leslie R.; Fischer, Marek; Vernazza, Pietro; Bernasconi, Enos; Battegay, Manuel; Ledergerber, Bruno; Günthard, Huldrych; Howe, Colin; Weber, Rainer; Perrin, Luc (2002). A Randomized Trial of Simplified Maintenance Therapy with Abacavir, Lamivudine, and Zidovudine in Human Immunodeficiency Virus Infection. Journal of infectious diseases, 185(9), pp. 1251-1260. The University of Chicago Press 10.1086/340312
Boubaker, K.; Flepp, M.; Sudre, P.; Furrer, Hansjakob; Haensel, A.; Hirschel, B.; Boggian, K.; Chave, J.-P.; Bernasconi, E.; Egger, M.; Opravil, M.; Rickenbach, M.; Francioli, P.; Telenti, A. (2001). Hyperlactatemia and Antiretroviral Therapy: The Swiss HIV Cohort Study. Clinical infectious diseases, 33(11), pp. 1931-1937. The University of Chicago Press 10.1086/324353
Furrer, Hansjakob; Chan, Phil; Weber, Rainer; Egger, Matthias (2001). Increased risk of wasting syndrome in HIV-infected travellers: prospective multicentre study. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95(5), pp. 484-486. Royal Society of Tropical Medicine and Hygiene 10.1016/S0035-9203(01)90011-2
Furrer, Hansjakob (2000). Prevalence and Clinical Significance of Splenomegaly in Asymptomatic Human Immunodeficiency Virus Type 1-Infected Adults. Clinical infectious diseases, 30(6), pp. 943-945. The University of Chicago Press 10.1086/313816
Kaiser, Laurent; Perrin, Luc; Hirschel, Bernard; Furrer, Hansjakob; Von Overbeck, Jan; Olmari, Maya; Yerly, Sabine (1995). Foscarnet Decreases Human Immunodeficiency Virus RNA. Journal of infectious diseases, 172(1), pp. 225-227. The University of Chicago Press 10.1093/infdis/172.1.225
Opravil, Milos; Pechère, Marc; Lazzarin, Adriano; Heald, Alison; Rüttimann, Sigmund; Iten, Anne; Furrer, Hansjakob; Oertle, Daniel; Praz, Gerard; Vuitton, Dominique A.; Hirschel, Bernard; Lüthy, Ruedi (1995). Dapsone/Pyrimethamine May Prevent Mycobacterial Disease in Immunosuppressed Patients Infected with the Human Immunodeficiency Virus. Clinical infectious diseases, 20(2), pp. 244-249. The University of Chicago Press 10.1093/clinids/20.2.244
